U.S. patent application number 12/795882 was filed with the patent office on 2010-12-09 for microorganisms having enhanced tolerance to inhibitors and stress.
This patent application is currently assigned to UT-BATTELLE, LLC. Invention is credited to Steven D. Brown, Shihui Yang.
Application Number | 20100311137 12/795882 |
Document ID | / |
Family ID | 43301036 |
Filed Date | 2010-12-09 |
United States Patent
Application |
20100311137 |
Kind Code |
A1 |
Brown; Steven D. ; et
al. |
December 9, 2010 |
Microorganisms Having Enhanced Tolerance To Inhibitors and
Stress
Abstract
The present invention provides genetically modified strains of
microorganisms that display enhanced tolerance to stress and/or
inhibitors such as sodium acetate and vanillin. The enhanced
tolerance can be achieved by increasing the expression of a protein
of the Sm-like superfamily such as a bacterial Hfq protein and a
fungal Sm or Lsm protein. Further, the present invention provides
methods of producing alcohol from biomass materials by using the
genetically modified microorganisms of the present invention.
Inventors: |
Brown; Steven D.;
(Knoxville, TN) ; Yang; Shihui; (Knoxville,
TN) |
Correspondence
Address: |
Scully Scott Murphy & Presser PC
400 Garden City Plaza, Suite 300
Garden City
NY
11530
US
|
Assignee: |
UT-BATTELLE, LLC
Oak Ridge
TN
|
Family ID: |
43301036 |
Appl. No.: |
12/795882 |
Filed: |
June 8, 2010 |
Related U.S. Patent Documents
|
|
|
|
|
|
Application
Number |
Filing Date |
Patent Number |
|
|
61184961 |
Jun 8, 2009 |
|
|
|
Current U.S.
Class: |
435/157 ;
435/252.3; 435/252.31; 435/252.33; 435/254.2; 435/254.21;
435/254.22; 435/254.23 |
Current CPC
Class: |
Y02E 50/10 20130101;
Y02E 50/16 20130101; C12N 1/22 20130101; Y02E 50/17 20130101; C07K
14/47 20130101; C12P 7/10 20130101 |
Class at
Publication: |
435/157 ;
435/252.3; 435/252.31; 435/252.33; 435/254.2; 435/254.21;
435/254.22; 435/254.23 |
International
Class: |
C12P 7/04 20060101
C12P007/04; C12N 1/21 20060101 C12N001/21; C12N 1/19 20060101
C12N001/19 |
Goverment Interests
[0002] This invention was made with government support under
Contract Number DE-AC05-00OR22725 between the United States
Department of Energy and UT-Battelle, LLC. The U.S. Government has
certain rights in this invention.
Claims
1. A genetically modified microorganism, wherein said genetic
modification comprises introduction of an expression vector
comprising the coding sequence of a protein of the Sm-like
superfamily, and wherein said genetic modification results in
elevated tolerance to stress or at least one inhibitor as compared
to without the genetic modification.
2. The microorganism of claim 1, wherein said microorganism is
selected from bacteria or fungi.
3. The microorganism of claim 2, wherein said microorganism is a
bacterium selected from the group consisting of Acetobacterium,
Bacillus, Streptococcus, Clostridium, Zymomonas, Anaerocellum,
Caldicellulosiruptor, Thermoanaerobacter, Gluconobacter, and E.
coli.
4. The microorganism of claim 3, wherein said bacterium is selected
from the group consisting of C. thermocellum, Z. mobilis,
Anaerocellum thermophilum, Caldicellulosiruptor saccharolyticus),
Thermoanaerobacter sp. X514, and E. coli.
5. The microorganism of claim 2, wherein said microorganism is a
bacterium and wherein said protein of the Sm-like superfamily is a
bacterial Hfq protein.
6. The microorganism of claim 5, wherein said Hfq protein comprises
an amino acid sequence selected from SEQ ID NO: 2, 4, 6, 8 or 10,
or a functional derivative or homolog thereof that shares at least
95% sequence identity therewith.
7. The microorganism of claim 5, wherein said microorganism is Z.
mobilis.
8. The microorganism of claim 7, wherein said Hfq protein comprises
the sequence as set forth in SEQ ID NO: 2.
9. The microorganism of claim 2, wherein said microorganism is a
fungal species selected from Saccharomyces sp., Kluyveromyces sp.,
Pichia sp., Candida sp., and Schizosaccharomycetes sp.
10. The microorganism of claim 9, wherein said fungal species is
yeast selected from S. cerevisiae or P. pastoris.
11. The microorganism of claim 10, wherein said protein of the
Sm-like superfamily is a yeast Sm or Lsm protein.
12. The microorganism of claim 11, wherein said protein comprises
an amino acid sequence selected from any one of SEQ ID NOS: 14, 16,
18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42, 44, 46, 48 or
50, or a functional derivative or homolog thereof that shares at
least 95% sequence identity therewith.
13. The microorganism of claim 1, wherein said expression vector is
a replicative vector or an integrative vector.
14. The microorganism of claim 1, wherein said stress is
environmental stress selected from the group of high temperatures,
low temperatures, low pH, oxidation, osmotic, and drought.
15. The microorganism of claim 1, wherein said at least one
inhibitor is selected from the group consisting of an acetate salt,
vanillin, furfural, hydroxymethylfurfural (HMF) and
H.sub.2O.sub.2.
16. The microorganism of claim 15, wherein said acetate salt is
selected from the group consisting of sodium acetate, ammonium
acetate and potassium acetate.
17. The microorganism of claim 1, wherein said enhanced tolerance
is characterized by ability to grow in a media containing sodium
acetate at a concentration of 195 mM.
18. A method of producing alcohol from a cellulosic biomass
material, comprising adding a genetically modified microorganism
according to any one of claims 1-17 to a fermentation mixture
comprising a cellulosic biomass material and/or fermentation
substrates derived from said cellulosic biomass material, allowing
said microorganism to ferment and produce alcohol, and recover
alcohol produced.
Description
CROSS REFERENCE TO RELATED APPLICATION
[0001] This application claims the benefit of priority from U.S.
Provisional Application No. 61/184,961, filed on Jun. 8, 2009, the
content of which in its entirety is incorporated herein by
reference.
FIELD OF THE INVENTION
[0003] This invention generally relates to the field of
microorganism and genetic modification thereof. In particular, the
invention relates to microorganisms that display enhanced tolerance
to stress and inhibitors as a result of increased expression of a
protein of the Sm-like superfamily such as bacterial Hfq and yeast
Sm or Lsm proteins. Such microorganisms are advantageous for use in
fermentation of biomass materials to produce biofuels such as
ethanol.
BACKGROUND OF THE INVENTION
[0004] Biomass-based bioenergy is crucial to meet the goal of
making cellulosic biofuels cost-competitive with gasoline.
Lignocellulosic materials represent an abundant feedstock for
cellulosic-biofuel production. A core challenge in converting
cellulosic material to biofuels such as ethanol and butanol is the
recalcitrance of biomass to breakdown. Because of the complex
structure of lignocellulosic biomass, pretreatment is necessary to
make it accessible for enzymatic attack. Severe biomass
pretreatments are required to release the sugars, which along with
by-products of fermentation can create inhibitors in the production
of ethanol or butanol, for example. During the pretreatment
processes, a range of inhibitory chemicals are formed that include
sugar degradation products such as furfural and hydroxymethyl
furfural (HMF); weak acids such as acetic, formic, and levulinic
acids; lignin degradation products such as the substituted
phenolics vanillin and lignin monomers. In addition, the metabolic
byproducts such as ethanol, lactate, and acetate also impact the
fermentation by slowing and potentially stopping the fermentation
prematurely. The increased lag phase and slower growth increases
the ethanol cost due to both ethanol production rate and total
ethanol yield decreases (Takahashi et al. 1999; Kadar et al.
2007).
[0005] Efficient conversion of lignocellulosic hydrolysates to
biofuel requires high-yield production and resistance to
industrially relevant stresses and inhibitors. To overcome the
issue of inhibition caused by pretreatment processes, there are two
approaches, one is to remove the inhibitor after pretreatment from
the biomass physically or chemically, which requires extra
equipment and time leading to increased costs. A second approach
utilizes inhibitor tolerant microorganisms for efficient
fermentation of lignocellulosic material to ethanol and their
utility is considered an industrial requirement (Almeida et al.
2007).
[0006] Zymomonas mobilis are gram-negative facultative anaerobic
bacteria with a number of desirable industrial characteristics,
such as high-specific productivity and ethanol yield, unique
anaerobic use of the Entner-Doudoroff pathway that results in low
cell mass formation, high ethanol tolerance (12%), pH 3.5-7.5 range
for ethanol production and has been generally regarded as safe
(GRAS) status (Swings and De Ley 1977; Rogers et al. 1984;
Gunasekaran and Raj 1999; Dien et al. 2003; Panesar et al. 2006;
Rogers et al. 2007). One drawback to using wild-type Z. mobilis is
its narrow substrate utilization range. However, recombinant Z.
mobilis strains have been developed to ferment pentose sugars such
as xylose and arabinose (Zhang et al. 1995; Deanda et al. 1996;
Mohagheghi et al. 2002). On the other hand, low tolerance to acetic
acid and decreased ethanol tolerance have been reported in
recombinant strains (Ranatunga et al. 1997; Lawford and Rousseau
1998; Lawford et al. 2001; Dien et al. 2003).
[0007] Acetic acid is an inhibitor produced by the de-acetylation
of hemicelluloses during biomass pretreatment. At pH 5.0, 36% of
acetic acid is in the uncharged and undissociated form (HAc) and is
able to permeate the Z. mobilis plasma membrane (Lawford and
Rousseau 1993). The inhibition mechanism has been ascribed to the
ability of the undissociated (protonated) form to cross the cell
membrane leading to uncoupling and anion accumulation causing
cytoplasmic acidification. Its importance comes from the
significant concentrations of acetate that are produced relative to
fermentable sugars (McMillan 1994) and the ratio of acetate to
fermentable sugars is particularly high in material from hardwoods
(Lawford and Rousseau 1993). Acetate may reach inhibitory levels
when pretreated biomass hydrolysates are concentrated to generate
high final ethanol concentrations or where process water is
recycled. Acetate removal processes have been described but they
are energy or chemical-intensive and their impact on processing
costs have yet to be determined (McMillan 1994).
[0008] An acetate tolerant Z. mobilis mutant (AcR) has been
generated by a random mutagenesis and selection strategy
(Joachimstahl and Rogers 1998). The AcR mutant was capable of
efficient ethanol production in the presence of 20 g/L sodium
acetate while the parent ZM4 was inhibited significantly above 12
g/L sodium acetate under the same conditions. A number of studies
have characterized the performance of recombinant Z. mobilis
strains able to utilize both C-5 and C-6 sugars, including under
acetate stress conditions (Lawford et al. 1999; Joachimsthal and
Rogers 2000; Lawford and Rousseau 2001). Acetic acid was shown to
be strongly inhibitory to wild-type derived strain ZM4(pZB5) on
xylose medium and nuclear magnetic resonance studies indicated
intracellular deenergization and acidification appeared to be the
major inhibition mechanisms (Kim et al. 2000). A recombinant strain
able to utilize both xylose (a C-5 sugar) and glucose (a C-6 sugar)
with increased acetate resistance was generated by transforming
plasmid pZBS into the AcR background (Jeon et al. 2002). Mohagheghi
et al. (2004) reported a recombinant Zymomonas mobilis 8b tolerated
up to 16 g/L acetic acid and achieved 82%-87% (w/w) ethanol yields
from pure glucose/xylose solutions.
[0009] Acetic acid bacteria are used for the industrial production
of vinegar and are intrinsically resistant to acetic acid. Although
the resistance mechanism is not completely understood, progress
toward this goal has been made in recent years. Spontaneous acetic
acid bacteria mutants for Acetobacter aceti (Okumura et al. 1985)
and several Acetobacter pasteurianus strains (Takemura et al. 1991;
Chinnawirotpisan et al. 2003) showed growth defects in the presence
of acetic acid, which was associated with loss of alcohol
dehydrogenase activity. Fukaya et al (1990) identified the aarA,
aarB, and aarC gene cluster as being important for conferring
acetic acid resistance using a genetic approach (Fukaya et al.
1990). aarA encodes citrate synthase and aarC encodes a protein
that is involved in acetate assimilation (Fukaya et al. 1993), and
the three aar genes have been suggested to support increased flux
through a complete but unusual citric acid cycle to lower
cytoplasmic acetate levels (Mullins et al. 2008). The presence of a
proton motive force-dependent efflux system for acetic acid has
been demonstrated as being important in A. aceti acetic acid
resistance, although the genetic determinant(s) remain to be
identified (Matsushita et al. 2005). In E. coli, over-expression of
the ATP-dependent helicase RecG has been reported to improve
resistance to weak organic acids including acetate (Steiner and
Sauer 2003). Baumler et al. (2006) describe the enhancement of acid
tolerance in Z. mobilis by the expression of a proton-buffering
peptide in acidified TSB (HCl (pH 3.0) or acetic acid (pH 3.5)),
glycine-HCl buffer (pH 3.0) and sodium acetate-acetic acid buffer
(pH 3.5) (Baumler et al. 2006). Baumler et al. (2006) also note
that the presence of the antibiotic also significantly increased
acid tolerance by an unknown mechanism.
[0010] Aerobic, stationary phase conditions were found to produce a
number of inhibitory secondary metabolites from Z. mobilis when
compared to anaerobic conditions at the same time point. The Z.
mobilis global regulator gene hfq has been identified as associated
with stress responses generated under aerobic stationary phase
conditions (Yang et al., 2009). Hfq is a bacterial member of the Sm
family of RNA-binding proteins, which acts by base-pairing with
target mRNAs and functions as a chaperone for non-coding small RNA
(sRNA) in E. coli (Valentin-Hansen et al. 2004; Zhang et al. 2002;
Zhang et al. 2003). E. coli Hfq is involved in regulating various
processes and deletion of hfq has pleiotropic phenotypes, including
slow growth, osmosensitivity, increased oxidation of carbon
sources, and altered patterns of protein synthesis in E. coli
(Valentin-Hansen et al. 2004; Tsui et al. 1994). E. coli Hfq has
also been reported to affect genes involved in amino acid
biosynthesis, sugar uptake, metabolism and energetics (Guisbert et
al. 2007). The expression of thirteen ribosomal genes was
down-regulated in hfq mutant background in E. coli (Guisbert et al.
2007). Hfq also up-regulated sugar uptake transporters and enzymes
involved in glycolysis and fermentation such as pgk and pykA, and
adhE (Guisbert et al. 2007). E. coli Hfq is also involved in
regulation of general stress responses that are mediated by
alternative sigma factors such as RpoS, RpoE and RpoH. Cells
lacking Hfq induce the RpoE-mediated envelope stress response and
rpoH is also induced in cells lacking Hfq (Guisbert et al. 2007),
which is consistent with our results that Z. mobilis hfq was less
abundant in aerobic fermentation condition in ZM4 at 26 h
post-inoculation and was rpoH induced (Yang et al. 2009).
SUMMARY OF THE INVENTION
[0011] It has been identified in accordance with the present
invention that increased expression of a protein of the Sm-like
superfamily in a microorganism confers enhanced tolerance to stress
and inhibitors such as sodium acetate, ammonium acetate, potassium
acetate, vanillin, furfural, hydroxymethylfurfural (HMF) and
H.sub.2O.sub.2. In accordance with the present invention,
microorganisms can be genetically modified to increase the
expression of a protein of the Sm-like superfamily to achieve
enhanced tolerance to stress and inhibitors. Such genetically
modified microorganisms are particularly useful for production of
biofuels based on fermentation of biomass materials.
[0012] In one aspect, the invention is directed to genetically
modified microorganisms that display enhanced tolerance to stress
and/or inhibitors as a result of increased expression of a protein
of the Sm-like superfamily in the microorganisms.
[0013] In one embodiment, the microorganism is a genetically
engineered bacterial strain, and the protein being expressed at an
elevated level is a bacterial Hfq protein.
[0014] Bacteria contemplated by the present invention include both
Gram-negative and Gram positive bacteria. Examples of bacteria of
particular interest include Acetobacterium, Bacillus,
Streptococcus, Clostridium (e.g., C. thermocellum), Zymomonas sp.
(e.g., Z. mobilis), Anaerocellum (e.g., Anaerocellum thermophilum),
Caldicellulosiruptor (e.g., C. saccharolyticus), Thermoanaerobacter
(e.g., Thermoanaerobacter sp. X514), Gluconobacter, and E.
coli.
[0015] Bacterial strains that display enhanced tolerance to stress
and/or inhibitors can be generated, e.g., by introducing to a
bacterial strain an expression vector which includes the coding
sequence of a bacterial Hfq protein. The expression vector directs
the expression of the Hfq protein as a replicative plasmid, or
mediates the integration of the coding sequence into the host
genome to achieve chromosomal expression. Preferably, the bacterial
Hfq protein in the vector is identical with or substantially
homologous with an endogenous Hfq protein of the recipient
bacterial strain.
[0016] In specific embodiments, the expression vector includes the
coding sequence of a bacterial Hfq protein having an amino acid
sequence selected from the group consisting of SEQ ID NO: 2 (Z.
mobilis ZM4), SEQ ID NO: 4 (E. coli), SEQ ID NO: 6 (Clostridium
thermocellum), SEQ ID NO: 8 (Anaerocellum thermophilum), SEQ ID NO:
10 (Caldicellulosiruptor saccharolyticus), SEQ ID NO: 12
(Thermoanaerobacter sp. X514), and functional derivatives
thereof.
[0017] In a further embodiment, the invention is directed to
genetically engineered fungal strains that display enhanced
tolerance to stress and/or inhibitors. Examples of fungi include
Saccharomyces sp. (e.g., S. cerevisiae), Kluyveromyces sp., Pichia
sp. (e.g., Pichia pastoris), Candida sp., and Schizosaccharomycetes
sp.
[0018] Such fungal strains can be generated, e.g., by introducing
to a fungal strain an expression vector which includes the coding
sequence of a fungal protein of the Sm-like superfamily. Similarly,
the expression vector can be a replicative vector or integrative
vector. Preferably, the fungal protein of the Sm-like superfamily
in the expression vector is identical with or substantially
homologous with an endogenous Sm-like protein of the fungal
strain.
[0019] In specific embodiments, the expression vector includes the
coding sequence of a fungal protein of the Sm-like superfamily
having an amino acid sequence selected from the group consisting of
SEQ ID NOS: 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40,
42, 44, 46, 48 and 50 (representing 19 S. cerevisiae Sm and Lsm
proteins) and functional derivatives thereof.
[0020] The genetically modified microorganisms that display
enhanced tolerance to stress and inhibitors can be additionally
modified as appropriate, for example, by transformation with
additional recombinant genes or sequences suitable for fermentation
and production of ethanol. For example, the bacterial and fungal
strains can be additionally modified so as to have the ability to
utilize C5 sugars such as xylose and arabinose in addition to C6
sugars.
[0021] In a further aspect, the present invent provides a method of
producing biofuels from cellulosic biomass based on use of the
microbial strains that are able to grow at elevated concentrations
of inhibitors and/or under stress conditions.
BRIEF DESCRIPTION OF THE DRAWINGS
[0022] FIGS. 1A-1E. Domain and motif sites of Z. mobilis Hfq (A),
E. coli Hfq (B), S. cerevisiae Sm B (C), and S. cerevisiae Lsm1 (D)
proteins. Bacterial Hfq alignment and Clustal W (E). Residues that
are identical across the species are indicated by "*", and residues
that are not identical but conserved in function across the species
are indicated by ":".
[0023] FIG. 2A. Graphic map of the low copy number Gateway.RTM.
compatible plasmid pBBR3-DEST42. Tc(R): Tetracycline resistance
gene tet; Cm: chloramphenicol resistance gene cat. attR1 and attR2
are recombination sites allowing recombinational cloning of the
gene of interest from an entry clone; ccdB is ccdB gene allowing
negative selection of expression clones.
[0024] FIG. 2B. The insertion position and complementation region
of ZMO0347 as well as the primers and mutation position. ZMO0346,
ZMO0347, and ZMO0348 are Z. mobilis ZM4 genes. hfq_MF and hfq_MR
are primers used for insertional mutant construction using pKNOCK
mutagenesis system. Hfq_CF and Hfq_CR are primers used to clone the
hfq gene into pBBR3-DEST42 for complementation, which resulted in a
plasmid called as p42-0347. The primer sequences are: hfq_MF:
cggagagatggtcagtcaca (SEQ ID NO: 51); hfq_MR: ttcttgctgctgcataatcg
(SEQ ID NO: 52); Hfq_CF: atggccgaaaaggtcaacaatc (SEQ ID NO: 53);
Hfq_CR: atcctcgtctcgcctttctgtc (SEQ ID NO: 54).
[0025] FIGS. 3A-3C. Hfq is responsible for sodium acetate tolerance
of Z. mobilis. Z. mobilis strains were grown in RM (pH5.0)
overnight, 20-.mu.L culture were then transferred into 250-.mu.L RM
media in the Bioscreen plate. The growth differences of different
strains were monitored by Bioscreen (GrowthCurve, Mass.) under
anaerobic conditions in RM (pH5.0) containing 0, 12, and 16 g/L
NaAc (A, B, C respectively). Strains included in this study are:
ZM4: Zymomonas mobilis ZM4 wild-type; AcR: ZM4 acetate tolerant
mutant (Joachimstahl 1998); ZM4 (p42-0347): ZM4 containing a
gateway plasmid p42-0347 over-expressing ZM4 gene ZMO0347;
AcRIM0347: AcR insertional mutant of ZMO0347; AcRIM0347 (p42-0347):
AcRIM0347 containing gateway plasmid p42-0347 over-expressing ZM4
gene ZMO0347. This experiment has been repeated at least three
times with similar result. Triplicates were used for each
condition.
[0026] FIGS. 4A-4E. Hfq contributes to Z. mobilis acetate
tolerance. Z. mobilis strains were grown in RM (pH5.0) overnight,
5-.mu.L culture were then transferred into 250-.mu.L RM media in
the Bioscreen plate. The growth differences of different strains
were monitored by Bioscreen (Growth Curves USA, NJ) under anaerobic
conditions; in RM, pH 5.0 (A), RM with 195 mM NaCl, pH 5.0 (B), 195
mM NaAc, pH 5.0 (C), 195mM NH.sub.4OAc, pH 5.0 (D), or 195 mM KAc,
pH 5.0 (E). Strains included in this study are: ZM4: Zymomonas
mobilis ZM4 wild-type; AcR: ZM4 acetate tolerant mutant; ZM4
(p42-0347): ZM4 containing a gateway plasmid p42-0347 to express
ZM4 gene ZMO0347; AcRIM0347: AcR insertional mutant of ZMO0347;
AcRIM0347 (p42-0347): AcRIM0347 containing gateway plasmid
p42-0347. This experiment has been repeated at least three times
with similar result. Duplicate biological replicates were used for
each condition.
[0027] FIGS. 5A-5E. Z. mobilis Hfq conferred tolerance to different
classes of pretreatment inhibitors. Z. mobilis strains were grown
in RM (pH 5.0) overnight, 5-.mu.L culture were then transferred
into 250-.mu.L RM media in the Bioscreen plate. The growth
differences of different strains were monitored by Bioscreen
(Growth Curves USA, NJ) under anaerobic conditions in RM, pH 5.0
(A), RM with 1 g/L vanillin, pH 5.0 (B), 1 g/L furfural, pH 5.0
(C), 1 g/L HMF, pH 5.0 (D) and 0.001% H.sub.2O.sub.2 (E). Strains
included in this study are: ZM4: Zymomonas mobilis ZM4 wild-type;
AcR: ZM4 acetate tolerant mutant; AcRIM0347: AcR insertional mutant
of ZMO0347; AcRIM0347 (p42-0347): AcRIM0347 containing gateway
plasmid p42-0347 over-expressing ZM4 gene ZMO0347. This experiment
has been repeated at least three times with similar result for
hydrogen peroxide growth and in duplicate for the vanillin
growth.
[0028] FIGS. 6A-6B. Lsm-like proteins in S. cerevisiae are
responsible for sodium acetate tolerance. S. cerevisiae strains
were grown in CM with 2% glucose for wild-type BY4741 and the
deletion mutants, CM with 2% glucose minus uracil for GST
over-expression strains. Five-.mu.L culture was then transferred
into 300-.mu.L CM broth in the Bioscreen plate. The growth
differences of different strains were monitored by Bioscreen
(Growth Curve USA, NJ) containing 40 g/L sodium acetate for yeast
deletion mutants (A) and GST over-expression strains (B). This
experiment has been repeated at least three times with similar
result.
[0029] FIGS. 7A-7P. Lsm proteins in S. cerevisiae are involved in
multiple inhibitor tolerance. S. cerevisiae strains were grown in
CM with 2% glucose (CM+glucose) for wild-type BY4741 and the
deletion mutants, CM with 2% glucose and 2% galactose minus uracil
(CM+glucose+2% galactose) for GST overexpression strains. A 5-.mu.L
culture was then transferred into 250-.mu.L CM broth in the
Bioscreen plate. The growth differences of different deletion
mutant strains were monitored by Bioscreen (Growth Curves USA, NJ)
in CM+glucose at pH 5.5 (A), CM+glucose with 305 mM NaCl, pH 5.5
(B), 305 mM NaAc, pH 5.5 (C), 305 mM NH.sub.4OAc, pH 5.5 (D), and
305 mM KAc, pH 5.5 (E), 0.75 g/L vanillin, pH 5.5 (F), 1.5 g/L
furfural, pH 5.5 (G), and 1.5 g/L HMF, pH 5.5 (H). The growth
differences of different GST-over-expressing strains were monitored
by Bioscreen (Growth Curves USA, NJ) in CM+glucose+2% galactose at
pH 5.5 (I), CM+glucose+2% galactose with 305 mM NaCl, pH 5.5 (J),
305 mM NaAc, pH 5.5 (K), 305 mM NH.sub.4OAc, pH 5.5 (L), 305 mM
KAc, pH 5.5 (M), 0.75 g/L vanillin, pH 5.5 (N), 1.5 g/L furfural,
pH 5.5 (O), and 1.5 g/L HMF, pH 5.5 (P). Strains included in this
study are listed in table 1. This experiment has been repeated at
least three times with similar result.
DETAILED DESCRIPTION OF THE INVENTION
[0030] It has been identified in accordance with the present
invention that increased expression of a protein of the Sm-like
superfamily in a microorganism confers enhanced tolerance to stress
and inhibitors. Based on this discovery, the present invention
provides strains of microorganisms displaying enhanced tolerance to
stress and/or inhibitors, which are particularly advantageous for
use in fermentation of biomass materials to produce biofuels.
[0031] In one aspect, the invention is directed to genetically
modified strains of microorganisms that display enhanced tolerance
to stress and/or growth inhibitor as a result of increased
expression of a protein of the Sm-like superfamily in the
microorganisms.
[0032] Sm-like superfamily proteins are a highly conserved family
of proteins found in eukaryotes, archaea and bacteria, and are
characterized by an Sm-like superfamily domain having two conserved
motifs referred to as Sm1 motif and Sm2 motif. The Sm1 and Sm2
motifs were first defined for human Sm snRNP proteins (Hermann et
al. 1995), and were subsequently found to be highly conserved in
other Sm and Lsm (Sm-like) proteins in eukaryotes including plant,
drosophila, C. elegans, and S. cerevisiae. Eukaryotic Sm and Lsm
proteins are integral to RNA processing and mRNA degradation
complexes. Subsequently, the E. coli global response regulator Hfq
was reported to be a homolog of the Sm and Lsm proteins (Zhang et
al. 2002). The bacterial Hfq proteins contain a first region that
shares significant similarity with the Sm1 motif found in
eukaryotes, and a second region of particularly high conservation
among the bacterial proteins which contains a number of conserved
hydrophobic residues that align with hydrophobic residues found in
the Sm2 motif of eukaryotic cells (Zhang et al. 2002). Similar to
the eukaryotic Sm and Lsm proteins, the E. coli Hfq protein also
forms a multisubunit ring and is believed to also function to
enhance RNA-RNA pairing.
[0033] As used herein, the term "Sm-like superfamily" includes both
Sm and Lsm proteins of eukaryotes and archaea, and Hfq proteins of
bacteria.
[0034] A eukaryotic protein is considered to be a protein of the
Sm-like superfamily in the context of the present invention if the
protein contains an Sm-like superfamily domain characterized by the
Sm1motif and Sm2 motif defined by Hermann et al. (1995).
Specifically, the Sm1 motif typically spans 32 amino acids, with
positions 13 and 23 being Gly and Asn, respectively, positions 1,
3, 11, 15, 18 and 26 being a hydrophobic residue, and positions 19
and 31 being an acidic amino acid (Asp or Glu). The Sm2 motif
typically spans only 14 amino acids, and has the consensus sequence
(I or L)(R or K)(G or C) at positions 6-8, with positions 1, 4, 11,
13 and 14 being a hydrophobic residue, and positions 9-10 being a
hydrophilic residue. Examples of eukaryotic proteins of the Sm-like
superfamily include S. cerevisiae Sm B, Sm D1, Sm D2, Sm D3, Sm E,
Sm F, Sm G, Lsm1, Lsm2, Lsm3, Lsm4, Lsm5, Lsm6, Lsm7, Lsm8, Lsm9,
Lsm 13, and Lsm16 (SEQ ID NOS: 14, 16, 18, 20, 22, 24, 26, 28, 30,
32, 34, 36, 38, 40, 42, 44, 46, 48 and 50, respectively). The
locations of Sm1 and Sm2 motifs are illustrated for Sm B and Lsm1
proteins in FIGS. 1C-1D.
[0035] In the context of the present invention, a bacterial protein
is considered to be an Hfq protein and therefore a protein of the
Sm-like superfamily if the bacterial protein contains an Sm-like
superfamily domain characterized by a first motif similar to the
Sm1 motif of eukaryotic proteins defined above, and a second highly
conserved region. Generally, the bacterial Sm1 motif spans 26 amino
acids, and like the eukaryotic Sm1 motif, has Gly at position 13,
an acidic amino acid at position 19 (typically Asp), a hydrophobic
residue at positions 1 (preferably V), 3, 11 (preferably L), 15 and
18 (preferably F). Additionally, the second highly conserved region
("the bacterial Sm2 motif") generally spans 12 amino acids, and has
a "KHA" sequence at positions 6-8; and preferably, with Y, I and S
at positions 5, 9, and 10, respectively, and with a hydrophobic
residue at positions 3-4 and 11. Examples of bacterial Hfq proteins
include SEQ ID NO: 2 (Z. mobilis ZM4), SEQ ID NO: 4 (E. coli), SEQ
ID NO: 6 (Clostridium thermocellum), SEQ ID NO: 8 (Anaerocellum
thermophilum), SEQ ID NO: 10 (Caldicellulosiruptor
saccharolyticus), and SEQ ID NO: 12 (Thermoanaerobacter sp. X514).
Alignment of these bacterial Hfq proteins is provided in FIG. 1B,
and the locations of the Sm-like superfamily domain including the
Sm1 and Sm2 motifs of Z. mobilis and E. coli proteins are
illustrated in FIG. 1A. It is clear that these six bacterial Hfq
proteins share significant homologies, having conserved V, L, G, L,
G, F, D and F at positions 1, 5, 8, 11, 13, 18, 19 and 21 of the
SmaI motif, and Y, K, H, A, I, and S at positions 5-10 of the Sm2
motif.
[0036] Functional derivatives and homologs of a given protein of
the Sm-like superfamily are also suitable for use in the present
invention. As used herein, "functional derivatives" and "homologs"
of a protein of the Sm-like superfamily refer to proteins that
share at least 45% identity or similarity, or preferably at least
50%, 60%, 75%, or 85% identity or similarity, or more preferably
90%, 95%, 98%, or 99% identity or similarity, with the protein of
the Sm-like superfamily. Similarity between two protein sequences
can be determined, for example, using the well known Lipman-Pearson
Protein Alignment program with the following choice of parameters:
Ktuple=2, Gap Penalty=4, and Gap Length Penalty=12. Preferably, the
derivatives and homologs share consensus motifs of the Sm-like
superfamily, which are believed to be critical to the function of
the proteins.
[0037] A functional derivative of a given protein includes derives
where modifications are made to non-conserved residues, as well as
a functional or enzymatically active fragment of the protein. The
term "functional fragment" or "enzymatically active fragment" means
a polypeptide fragment of a full length protein, which
substantially retains the activity of the full-length protein. By
"substantially" it is meant at least about 50%, or preferably at
least 70%, or even 80% or more of the activity of the full-length
protein is retained.
[0038] The genetically engineered microbial strains of the present
invention display enhanced tolerance to stress and/or one or more
inhibitors as a result of increased expression of a protein of the
Sm-like superfamily.
[0039] The term "stress", as used herein, refers generally to
environmental stress, i.e., stress received from the environment,
such as high temperatures, low temperatures, low pH, oxidation
(i.e., the presence of reactive oxidative species such as
H.sub.2O.sub.2), osmotic, drought, the presence of inhibitors, or
nutrient limit such as starvation, among others. For example, "cold
stress" is stress on microorganism due to exposure to environments
below the minimum optimal growth temperature of the microorganism.
"Drought stress" is stress due to exposure of the microorganism to
environments under the minimum optimal growth moisture
concentration. "Osmotic stress" is stress on microorganisms due to
exposure of the microorganisms to environments over or under the
maximum or minimum optimal growth osmotic of the
microorganisms.
[0040] The term "inhibitors" as used herein refer particularly to
inhibitory chemical compounds that are formed during biomass
pretreatments, including sugar degradation products such as
furfural and hydroxymethyl furfural (HMF), weak acids such as
acetic, formic, and levulinic acids, lignin degradation products
such as the substituted phenolics vanillin and lignin monomers,
reactive oxidative species generating hydrogen peroxide
(H.sub.2O.sub.2) and vanillin, as well as metabolic byproducts such
as ethanol, lactate, and acetate. A particularly desirable trait of
microorganisms is an enhanced tolerance to sodium and acetate ions,
e.g., in the form of sodium acetate, ammonium acetate, and
potassium acetate.
[0041] In the present invention, microorganisms with enhanced
tolerance to stress and/or one or more inhibitors refer to
microorganisms which, as a result of genetic modification to
increase the level of proteins of the Sm-like superfamily in the
microorganisms, demonstrate improved tolerance as compared to
microorganisms without the genetic modification. Improved tolerance
can be determined by an improved growth profile (either as a
shorter lag phase, a shorter doubling time, or a higher maximum
density) under a given stress condition or inhibitor concentration.
Alternatively, improved tolerance can be determined by an increase
in the concentration of an inhibitory molecule which the
microorganisms can tolerate.
[0042] For example, microorganisms having an elevated expression of
Sm-like superfamily proteins exhibit enhanced tolerance to acetate.
"Tolerance to acetate" is meant herein to include resistance to
acetate salts including, for example, sodium acetate, ammonium
acetate and potassium acetate, and/or to acetic acid. Tolerance of
a strain to acetate can be determined by assessing the growth of
the strain in media containing various concentrations of acetate
(e.g., sodium acetate). The microbial strains containing a
desirable genetic modification of the present invention are able to
grow in media containing a higher concentration of acetate (e.g.,
sodium acetate) than the unmodified strains. For example, the
concentration of sodium acetate that can be tolerated by a strain
can be increased by 15%, 20%, 30%, or 50% or higher, as a result of
a genetic modification. As demonstrated herein below, wild type Z.
mobilis strain ZM4 is unable to grow in media containing 16 g/L
(195 mM) sodium acetate, while ZM4-p42-0347 (expressing additional
ZM4 Hfq proteins) is able to grow at this concentration.
Alternatively, "enhanced tolerance" can be measured by a shorter
lag time (e.g., shortened by 10%, 20%, 30% or 50% or greater), a
shorter doubling time (e.g., shortened by 10%, 20%, 30% or 50% or
greater) or a higher cell density reached at the end of the
exponential growth phase (e.g., 25%, 50%, 75%, 100%, 150%, 200%,
500%, or even 1000% or higher cell density). See FIGS. 3A-3C.
[0043] Microorganisms encompassed within the scope of the present
invention include both bacteria and fungi.
[0044] In accordance with the present invention, bacterial strains
having enhanced tolerance to stress and inhibitors as a result of
increased expression of Sm-superfamily proteins include both
Gram-positive and Gram-negative bacteria. Examples of Gram-positive
bacteria include those from the genus of phylum Firmicutes,
particularly strains of Acetobacterium, Bacillus, Streptococcus,
Clostridium (e.g., C. thermocellum), Anaerocellum (e.g.,
Anaerocellum thermophilum), Caldicellulosiruptor (e.g., C.
saccharolyticus), and Thermoanaerobacter (e.g., Thermoanaerobacter
sp. X514). Examples of Gram-negative bacteria of particular
interest include those generally considered medically safe, such as
Zymomonas sp. (e.g., Z. mobilis), E. coli, Gluconobacter sp. (e.g.,
Gluconobacter oxydans, previously known as Acetobacter suboxydans),
Cyanobacteria, Green sulfur and Green non-sulfur bacteria.
[0045] Fungal strains contemplated by the present invention include
filamentous and unicellular fungal species, particularly the
species from the class of Ascomycota, for example, Saccharomyces
sp., Kluyveromyces sp., Pichia sp., Candida sp., and
Schizosaccharomycetes sp. Preferred fungal strains contemplated by
the present invention are S. cerevisiae, S. pombe, and Pichia
pastoris. Where the fungal strains are S. cerevisiae, additional
genetic modifications are preferred besides the genetic
modification that results in an increased expression of a Sm-like
superfamily protein. For example, S. cerevisiae is also modified
such that the strain is able to utilize C5 sugars.
[0046] Strains of microorganisms that display enhanced tolerance to
stress and/or inhibitors as a result of increased expression of a
Sm-like superfamily protein can be made using any of the known
genetic engineering techniques. For example, the 5' upstream
regulatory region of an endogenous Sm-like superfamily gene can be
modified to achieve enhanced expression of the encoded endogenous
Sm-like superfamily protein.
[0047] In one embodiment, a microbial strain having enhanced
tolerance is created by introducing an exogenous expression vector
into the strain which contains the coding sequence of a protein of
the Sm-like superfamily.
[0048] In a preferred embodiment, the protein encoded by the
expression vector is identical with an endogenous protein of the
Sm-like superfamily or a functional derivative thereof, even though
homologs from other related species can also be utilized.
[0049] Generally, the nucleotide sequence coding for a protein of
the Sm-like superfamily is placed in an operably linkage to a
promoter and a 3' termination sequence that are functional in a
recipient microbial host. The promoter can be a constitutive
promoter or an inducible promoter. The promoter can be the native
promoter of the Sm-like superfamily gene being expressed, or a
heterologous promoter from a different gene. Promoters suitable for
use in expression in a bacterial host include, for example, lac
promoter, T7, T3 and SP6 phage RNA polymerase promoters. Specific
examples of promoters suitable for use in expression in Zymomonas
species include Z. mobilis pdc promoter and adhB promoter. Specific
examples of promoters suitable for use in expression in yeast
including S. cerevisiae include adhl+(constitutive high
expression), fbpl+(carbon source responsive), a
tetracycline-repressible system based on the CaMV promoter, and the
nmtl+(no message in thiamine) promoter. These and other examples of
promoters are well documented in the art.
[0050] A variety of vector backbones can be used for purpose of the
present invention. Choices of vectors suitable for transformation
and expression in bacteria and fungi have been well documented in
the art. For example, numerous plasmids have been reported for
transformation and expression in Zymomonas, including, e.g., pZB
serial plasmids developed based on Zymomonas cryptic plasmid, as
described in U.S. Pat. Nos. 5,712,133, 5,726,053, and 5,843,760,
and a cloning-compatible broad-host-range destination vector
described by Pelletier et al. (2008), among many others.
[0051] In addition to the Sm-like superfamily protein expression
unit, the expression vector can include other sequences where
appropriate, such as sequences for maintenance and selection of the
vector, e.g., a selection marker gene and a replication origin. The
selection marker gene can be a gene that confers resistance to
antibiotics such as ampicillin resistance (Amp.sup.r), tetracycline
resistance (Tet.sup.r), neomycin resistance, hygromycin resistance,
and zeocin resistance (Zeo.sup.r) genes, or a gene that provides
selection based on media supplement and nutrition.
[0052] The vector can be a replicative vector (such as a
replicating circular plasmid), or an integrative vector which
mediates the introduction of the vector into a recipient cell and
subsequent integration of the vector into the host genome for
chromosomal expression.
[0053] For industrial applications, the inhibitors generated from
the biomass pretreatments will select for plasmid maintenance where
hfq expression confers an advantage to the strain (i.e., enhanced
tolerance to inhibitors) in the absence of additional marker or
antibiotic selection. The vectors can also be modified to include
the parDE genes to enhance plasmid stability in bacteria in the
absence of selection using standard molecular biology approaches,
as described in the art (Brown et al., 2002; Pecota et al., 1997).
Alternatively and preferably, the desired expression unit (such as
an hfq coding sequence operably linked to a promoter) is integrated
into the chromosome of the microorganism for expression and
enhanced stability. Methods for chromosomal integration in bacteria
include modified homologous Campbell-type recombination (Kalogeraki
et al. 1997) or transposition (Koch et al. 2001). Methods for
chromosomal integration in yeast are well known and are described
in Amberg et al. (2005).
[0054] An expression vector can be introduced into a microbial host
by various approaches known in the art, including transformation
(e.g., chemical reagent based transformation), electroporation and
conjugation.
[0055] The genetic modification to a microbial strain results in an
increased expression of a Sm-like superfamily protein. Where the
exogenously introduced expression unit codes for a protein
identical with an endogenous protein, the level of such protein
(expressed from both the native sequence and the exogenous
sequence) is increased. Where the exogenously introduced expression
unit codes for a protein that is not identical with any endogenous
protein but is a functional derivative of or most homologous to an
endogenous protein, the collective level of the endogenous protein
and the exogenous protein is increased as compared to the
unmodified strain. The extent of increase in expression
contemplated by the present invention is at least 40%, 50%, 75%,
100% (i.e., twice the level of parental strain), or more preferably
at least four or five times, or even more preferably at least ten
to fifteen times, the level of parental strain. As a practical
matter, the level of expression can be assessed both at the mRNA
level and at the protein level.
[0056] Pretreatment of biomass by chemical or enzymatic methods
yields a mixture of hexose sugars (C6 sugars, primarily glucose and
mannose) and pentose sugars (C5 sugars, primarily xylose and
arabinose). The fermentation of almost all the available C6 and C5
sugars to ethanol or other liquid biofuel is critical to the
overall economics of these processes. Most microorganisms are able
to ferment glucose but few have been reported to utilize xylose
efficiently and even fewer ferment this pentose to ethanol.
[0057] The genetically modified strains of microorganisms of the
present invention, which display enhanced tolerance to stress
and/or one or more inhibitors as a result of increased expression
of a Sm-like superfamily protein, can be additionally modified as
appropriate. For example, Z. mobilis strains overexpressing Z.
mobilis Hfq can be additionally modified in order to expand the
range of substrates that can be utilized by the strains for
efficient ethanol production. For instance, Z. mobilis strains
over-expressing Hfq can also be introduced with additional genes so
that the strains can ferment xylose, arabinose or other pentose
sugars as the sole carbon source to produce ethanol. See, e.g.,
U.S. Pat. No. 5,514,583. Additionally, yeast strains
over-expressing a Sm or Lsm protein, particularly S. cerevisiae
strains, can be additionally modified to have an enhanced ability
to ferment xylose, arabinose or other pentose sugars to produce
ethanol. For example, yeast cells can be modified to overexpress
(via transformation with additional expression unit) xylose
reductase, xylulokinase, or xylose isomerase; or modified to have
reduced expression of xylitol dehydrogenase, PHO13 or a PHO13
ortholog. See, e.g., U.S. Pat. No. 7,285,403, US 20060234364 A1,
and US 20080254524 A1, the teachings of which are incorporated
herein by reference.
[0058] The isolated or genetically modified microbial strains of
the present invention are particularly useful for production of
biofuels based on fermentation of biomass materials. Therefore, in
a further aspect, the present invent provides a method of producing
biofuels from cellulosic biomass based on use of the microbial
strains of the present invention that are able to grow at elevated
concentrations of acetate.
[0059] Biofuels contemplated by the present invention include
particular the types of biologically produced fuels, such as
bioalcohols, based on the action of microorganisms and enzymes
through fermentation of biomass materials. Examples of bioalcohols
include ethanol, butanol, and propanol.
[0060] In a typical cellulosic biomass to alcohol process, raw
cellulosic biomass material is pretreated in order to convert, or
partially convert, cellulosic and hemicellulosic components into
enzymatically hydrolyzable components (e.g., poly- and
oligo-saccharides). The pretreatment process also serves to
separate the cellulosic and hemicellulosic components from solid
lignin components also present in the raw cellulosic material. The
pretreatment process typically involves reacting the raw cellulosic
biomass material, often as a finely divided mixture or slurry in
water, with an acid, such as sulfuric acid. Other common
pretreatment processes include, for example, hot water treatment,
wet oxidation, steam explosion, elevated temperature (e.g.,
boiling), alkali treatment and/or ammonia fiber explosion. The
pretreated biomass is then treated by a saccharification step in
which poly- and oligo-saccharides are enzymatically hydrolyzed into
simple sugars. The free sugars and/or oligosaccharides produced in
the saccharification step are then subjected to fermentation
conditions for the production of ethanol or butanol, for example.
Fermentation can be accomplished by combining one or more
fermenting microorganisms with the produced sugars under conditions
suitable for fermentation.
[0061] One can also add enzyme to the fermentor to aid in the
degradation of substrates or to enhance alcohol production. For
example, cellulase can be added to degrade cellulose to glucose
simultaneously with the fermentation of glucose to ethanol by
microorganisms in the same fermentor. Similarly, a hemicellulase
can be added to degrade hemicellulose.
[0062] Because the pretreatment processes and by-products of
fermentation can create a range of inhibitors including acetate, it
is especially advantageous to utilize the genetically modified
microbial strains described herein which display enhanced
resistance to acetate and are able to continue fermentation despite
acetate present in the fermentation broth, either in the
fermentation substrate carried over from pretreatment of biomass
material, or built up as a byproduct of fermentation.
[0063] For purpose of fermentation, one strain or a mixture of
several strains, some or all of which display enhanced tolerance to
stress and/or inhibitors, can be used.
[0064] Specific fermentation conditions can be determined by those
skilled in the art, and may depend on the particular feedstock or
substrates, the microorganisms chosen and the type of biofuel
desired. For example, when Zymomonas mobilis is employed, the
optimum pH conditions range from about 3.5 to about 7.5; substrate
concentrations of up to about 25% (based on glucose), and even
higher under certain conditions, may be used; and no oxygen is
needed at any stage for microorganism survival. Agitation is not
necessary but may enhance availability of substrate and diffusion
of ethanol.
[0065] After fermentation, alcohol is separated from the
fermentation broth by any of the many conventional techniques known
to separate alcohol from aqueous solutions, including evaporation,
distillation, solvent extraction and membrane separation. Particles
of substrate or microorganisms may be removed before separation to
enhance separation efficiency.
[0066] Table 1. List all the sequence identifiers for the
nucleotide and protein sequences of the Sm-like superfamily
molecules exemplified in the present application.
[0067] The present invention is further illustrated and by no means
limited by the following examples.
TABLE-US-00001 TABLE 1 SEQ ID NO Description 1 Zymomonas mobilis
hfq nucleotide 2 Zymomonas mobilis Hfq amino acid 3 E. coli hfq
nucleotide 4 E. coli Hfq amino acid 5 Clostridium thermocellum hfq
nucleotide 6 Clostridium thermocellum Hfq amino acid 7 Anaerocellum
thermophilum hfq nucleotide 8 Anaerocellum thermophilum Hfq amino
acid 9 Caldicellulosiruptor saccharolyticus hfq nucleotide 10
Caldicellulosiruptor saccharolyticus Hfq amino acid 11
Thermoanaerobacter sp. X514 hfq nucleotide 12 Thermoanaerobacter
sp. X514 Hfq amino acid 13 S. cerevisiae SMB1 nucleotide 14 S.
cerevisiae Sm B amino acid 15 S. cerevisiae SMD1 nucleotide 16 S.
cerevisiae Sm D1 amino acid 17 S. cerevisiae SMD2 nucleotide 18 S.
cerevisiae Sm D2 amino acid 19 S. cerevisiae SMD3 nucleotide 20 S.
cerevisiae Sm D3 amino acid 21 S. cerevisiae SME1 nucleotide 22 S.
cerevisiae Sm E amino acid 23 S. cerevisiae SMX3 nucleotide 24 S.
cerevisiae Sm F amino acid 25 S. cerevisiae SMX2 nucleotide 26 S.
cerevisiae Sm G amino acid 27 S. cerevisiae LSM1 nucleotide 28 S.
cerevisiae Lsm1 amino acid 29 S. cerevisiae LSM2 nucleotide 30 S.
cerevisiae Lsm2 amino acid 31 S. cerevisiae LSM3 nucleotide 32 S.
cerevisiae Lsm3 amino acid 33 S. cerevisiae LSM4 nucleotide 34 S.
cerevisiae Lsm4 amino acid 35 S. cerevisiae LSM5 nucleotide 36 S.
cerevisiae Lsm5 amino acid 37 S. cerevisiae LSM6 nucleotide 38 S.
cerevisiae Lsm6 amino acid 39 S. cerevisiae LSM7 nucleotide 40 S.
cerevisiae Lsm7 amino acid 41 S. cerevisiae LSM8 nucleotide 42 S.
cerevisiae Lsm8 amino acid 43 S. cerevisiae LSM9 nucleotide 44 S.
cerevisiae Lsm9 amino acid 45 S. cerevisiae LSM12 nucleotide 46 S.
cerevisiae Lsm12 amino acid 47 S. cerevisiae LSM13 nucleotide 48 S.
cerevisiae Lsm13 amino acid 49 S. cerevisiae LSM16 nucleotide 50 S.
cerevisiae Lsm16 amino acid
Example 1
[0068] This example describes the materials and methods used in the
experiments described in the subsequent examples.
Strains and Culture Conditions
[0069] Bacterial strains and plasmids used in this study are listed
in Table 2. E. coli strains were cultured using Luria-Bertani (LB)
broth or plates. E. coli WM3064 was supplemented with 100 .mu.g/mL
diaminopimelic acid (DAP). Z. mobilis ZM4 was obtained from the
[0070] American Type Culture Collection (ATCC31821) and the Z.
mobilis acetate tolerant strain AcR has been described previously
(Joachimsthal et al. 2000). ZM4 and AcR were cultured in RM medium
at 30.degree. C. S. cerevisiae wild-type, deletion mutant and
GST-fusion ORF over-expression strains were obtained through Open
Biosystems (Huntsville, Ala.). S. cerevisiae strains were cultured
in rich YPD media. CM media with 2% glucose was used for S.
cerevisiae wild-type and S. cerevisiae deletion mutants, CM media
with 2% glucose minus uracil was used for S. cerevisiae GST-over
expressing strains, 2% galactose was used to induce the GST-fusion
strains. Plasmid-containing strains were routinely grown with
antibiotics at the following concentrations (.mu.g/mL): kanamycin
of 50 for E. coli and 200 for ZM4; tetracycline, 10 for E. coli and
20 for ZM4; and gentamicin, 10 for E. coli. G418 of 200 for S.
cerevisiae YKO deletion mutants. Growth was monitored
turbidometrically by measuring optical density at 600.sub.nm
periodically with the Bioscreen C automated microbiology growth
curve analysis system (Growth Curve USA, Piscataway, N.J.).
PCR and DNA Manipulations
[0071] Genomic DNA from Z. mobilis was isolated using a Wizard
Genomic DNA purification kit, following the manufacturer's
instructions (Promega, Madison, Wis.). The QIAprep Spin Miniprep
and HiSpeed Plasmid Midi kits (Qiagen, Valencia, Calif.) were used
for plasmid isolation, respectively. PCR, restriction enzyme
digestion, DNA ligation, DNA cloning, and DNA manipulations were
done following standard molecular biology approaches (Sambrook
2000).
Construction of the Novel Tetracycline Resistant Gateway Entry
Vector and ZMO0347 Over-Expression Plasmid
[0072] The construction of the broad-host-range, tetracycline
resistant Gateway.RTM. compatible destination plasmid vector
pBBR3DEST42 (FIG. 2A) was carried out essentially as described
previously (Pelletier et al. 2008), except that pBBRMCS-3
tetracycline resistance cassette was used in this study instead of
pBBRMCS-5 gentamicin resistance cassette used to construct
pBBR3DEST42. Briefly, pBBR1MCS3 plasmid DNA was restricted with the
KpnI and PvuI enzymes, treated with calf intestine alkaline
phosphatase and purified using a Qiagen gel purification kit
according to the manufacturer's instructions (Qiagen, Valencia,
Calif.). The recombination region on pET-DEST42 vector DNA
(Invitrogen, Carlsbad, Calif.) was PCR-amplified using the primers
42F and 42R that include KpnI and PvuI restriction sites as
described previously (Pelletier et al. 2008). The gel-purified PCR
product was ligated with pBBR1MCS3 KpnI/PvuI fragment with
Fast-Link.TM. DNA Ligation Kit (Epicentre, Madison, Wis.). Ligation
products were transformed into E. coli DB3.1 chemically competent
cells (Invitrogen, Carlsbad, Calif.) and the transformants were
selected by plating on LB agar plates containing tetracycline.
Individual colonies were grown overnight in LB containing 30
.mu.g/mL chloramphenicol and 10 .mu.g/mL tetracycline, and plasmid
DNA was prepared using QIAprep spin miniprep or HiSpeed Plasmid
Midi Kit following the manufacturer's protocol (Qiagen, Valencia,
Calif.). Plasmid DNA was digested with KpnI and PvuI and digestion
products were analyzed on an agarose gel to confirm the presence of
products of the expected sizes.
[0073] The construction of entry vector and expression clone of
target gene hfq (ZMO0347) was carried out as described previously
(Pelletier et al. 2008). Briefly, target gene hfq (ZMO0347) was PCR
amplified using AcR genomic DNA as template and primer hfq_CF and
hfq_CR as primers. PCR products were then cloned into Gateway.RTM.
entry clone pDONR221 using BP Clonase II enzyme mix following the
manufacturer's protocol (Invitrogen, Carlsbad, Calif.), and then
transformed into chemically competent DH5a cells (Invitrogen,
Carlsbad, Calif.) and plated onto LB with appropriate antibiotic
selection. The inserts were confirmed by sequencing using M13
forward and reverse primers (Integrated DNA Technologies, Inc.,
Coralville, Iowa). The confirmed entry clone vector was then
recombined with the destination vector pBBR3DEST42 using LR Clonase
II enzyme mix (Invitrogen Carlsbad, Calif.) to create the
expression vector as described previously (Pelletier et al. 2008).
The resulting expression vector construct was designed as p42-0347.
The plasmid construct p42-0347 was confirmed by sequencing using
BigDye Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems
Inc., Foster City, Calif.).
Mutant Plasmid Construction
[0074] Briefly, a 262-bp hfq internal part PCR product was purified
and cloned into pKnock-Km suicide vector (Alexeyev 1999) digested
with XbaI and HindIII restriction enzymes followed by
de-phosphorylation. The plasmid construct named as pKm-0347 was
then sequenced to confirm the presence of the target gene fragment,
which was then electroporated into E. coli WM3064 strain. The
transformant E. coli WM3064 (pKm-0347) was verified by PCR and
sequencing for the presence of correct plasmid construct pKm-0347.
E. coli WM3064 (pKm-0347) was then conjugated with AcR. The
conjugant of potential hfq mutant grown on RM plate with kanamycin
concentration of 200 .mu.g/mL and no DAP was selected based on PCR
size shift by comparing the PCR size of wild-type AcR and
conjugants using primer hfq_OCF and hfq_OCR (Table 2). Wild-type
AcR has a 1050-bp PCR product and hfq mutant candidates have a
2.9-kb PCR product. The PCR product was sequenced for mutant
confirmation.
[0075] The internal part of the Z. mobilis hfq gene (ZMO0347) was
amplified by PCR using primers hfq_MF and hfq_MR supplied by
MWG-Biotech (Huntsville, Ala.). The hfq gene and the primer
positions used for mutant construction and an hfq gene-expressing
vector are shown in FIG. 2B. The 262-bp hfq internal part PCR
product was then purified and cloned into pCR2.1-TOPO and then
transformed into E. coli TOPO one competent cell (Invitrogen,
Carlsbad, Calif.). Transformants containing the correct construct
were confirmed by PCR and sequencing. The plasmid was then
extracted using Qiagen Midiprep and digested XbaI and HindIII
restriction enzyme, the 262-bp hfq internal part was then purified
by Qiagen Gel purification kit. Similarly, pKnock-Km suicide vector
was also digested with XbaI and HindIII restriction enzyme followed
by de-phosphorylation, and then ligated with 262-bp purified hfq
internal part using Fast-Link.TM. DNA Ligation Kit (Epicentre,
Madison, Wis.). The ligation product (pKm-0347) was then
transformed into TransforMax EC100D pir-116 Electrocompetent E.
coli competent cells (Epicentre, Madison, Wis.) by electroporation.
Transformants containing plasmid pKm-0347 were selected on LB agar
plate with 50 .mu.g/mL kanamycin. The plasmid was then extracted
from the transformants, sequenced to confirm the presence of the
target gene fragment, and was then electroporated into E. coli
WM3064 strain. Transformants were verified by PCR and sequencing
using BigDye Terminator v3.1 Cycle Sequencing Kit (Applied
Biosystems Inc., Foster City, Calif.) for the presence of the
correct plasmid construct pKm-0347.
Plasmid Transformation of Z. mobilis
[0076] Z. mobilis wild-type ZM4 and acetate tolerant strain AcR
cultures were grown aerobically at 30.degree. C. in RM, and E. coli
WM3064 containing plasmid pKm-0347 or p42-0347 cultures were grown
at 37.degree. C. in LB containing 100 .mu.g/mL DAP and 10 .mu.g/mL
tetracycline to exponential phase. E. coli WM3064 cells containing
plasmid pKm-0347 or p42-0347 were washed with RM for three times by
centrifugation at 13,000 rpm for 1 min and resuspended in RM. AcR
cells were mixed with E. coli WM3064 (pKm-0347) cells in different
ratios (1:3, 1:1, and 3:1). Similarly, ZM4 or AcR cells were mixed
with E. coli WM3064 (p42-0347) cells in different ratios (1:3, 1:1,
and 3:1). The mixtures of cells were plated onto RM agar plates
with 100 .mu.g/mL DAP and 10 .mu.g/mL tetracycline for plasmid
p42-0347 conjugation or 50 .mu.g/mL kanamycin for plasmid pKm-0347
conjugation. The cells were incubated at 30.degree. C. overnight.
Conjugants were selected by plating on RM agar plates containing 20
.mu.g/mL tetracycline for p42-0347 plasmid conjugants or 200
.mu.g/mL kanamycin for pKm-0347plasmid conjugants at 30.degree. C.
The conjugants were confirmed for the presence of correct plasmid
constructs by PCR and sequencing using BigDye Terminator v3.1 Cycle
Sequencing Kit (Applied Biosystems Inc., Foster City, Calif.).
TABLE-US-00002 TABLE 2 Bacterial strains, plasmids and primers used
in this application. Strain, plasmid, or primer Genotype,
phenotype, or sequence of primer (5' to 3') Reference E. coli K-12
K-12 MG1655 Wild-type strain Joachimstahl et al. (1998) DH5.alpha.
F.sup.-.phi.80lacZ.DELTA.M15 .DELTA.(lacZYA-argF) U169 recA1 endA1
Novagen hsdR17(r.sub.k.sup.-, m.sub.k.sup.+) phoA supE44
.lamda..sup.- thi-1 gyrA96 relA1 DB3.1 F.sup.- gyrA462
endA1.DELTA.(sr1-recA) mcrB mrr hsdS20(r.sub.B.sup.-,
m.sub.B.sup.-) Invitrogen supE44 ara-14 galK2 lacY1 proA2
rpsL20(Sm.sup.R) xyl-5.lamda.- leu mtl1 WM3064 Denef et al. (2006)
BL21(DE3) F-ompT hsdSB(rB-mB-) gal dcm (DE3) Invitrogen Zymomonas
mobilis ZM4 ATCC31821 AcR ZM4 acetate tolerant strain generated by
random Joachimstahl et mutagenesis al. (1998) ZM4(p42-0347) ZM4
containing plasmid p42-0347 This application AcRIM0347 Insertional
mutant of AcR gene ZMO0347 This application AcRIM0347 (p42-0347)
AcRIM0347 containing plasmid p42-0347 This application S.
cerevisiae BY4741 MATa his31.DELTA.1 leu2.DELTA.0 ura3.DELTA.0
met15.DELTA.0-s288c background Open Biosystems YSC1021-547768
Yeast: Yeast Knock Out Strain, NHA1 Open Biosystems Clone Id: 14095
Accession: YLR138W YSC1021-551633 Yeast: Yeask Knock Out Strain,
VNX1 Open Biosystems Clone Id: 1123 Accession: YNL321W
YSC1021-553567 Yeast: Yeast Knock Out Strain, ARR3 Open Biosystems
Clone Id: 5616 Accession: YPR201W YSC1021-555633 Yeast: Yeast Knock
Out Strain, NHX1 Open Biosystems Clone Id: 4290 Accession: YDR456W
YSC1021-551475 Yeast: Yeast Knock Out Strain, transporter Open
Biosystems Clone Id: 610 Accession: YMR034C YSC1021-551268 Yeast:
Yeast Knock Out Strain, PSR1 Open Biosystems Clone Id: 1498
Accession: YLL010C YSC1021-551318 Yeast: Yeast Knock Out Strain,
PSR2 Open Biosystems Clone Id: 1574 Accession: YLR019W
YSC1021-555189 Yeast: Yeast Knock Out Strain Open Biosystems Clone
Id: 2341 Accession: YIR005W YSC1021-554440 Yeast: Yeast Knock Out
Strain Open Biosystems Clone Id: 1301 Accession: YJL124C
YSC1021-552226 Yeast: Yeast Knock Out Strain Open Biosystems Clone
Id: 4214 Accession: YDR378C YSC1021-556031 Yeast: Yeast Knock Out
Strain Open Biosystems Clone Id: 7383 Accession: YNL147W
YSC1021-552677 Yeast: Yeast Knock Out Strain Open Biosystems Clone
Id: 3501 Accession: YCR020C-A YSC1021-552563 Yeast: Yeast Knock Out
Strain Open Biosystems Clone Id: 1949 Accession: YHR121W
YSC1021-552280 Yeast: Yeast Knock Out Strain Open Biosystems Clone
Id: 255 Accession: YEL015W YSC1021-553518 Yeast: Yeast Knock Out
Strain Open Biosystems Clone Id: 5544 Accession: YPR129W
YSC1021-553919 Yeast: Yeast Knock Out Strain Open Biosystems Clone
Id: 3618 Accession: YDR259C YAP6 YSC4515-98809240 Yeast GST-Tagged
Strain Open Biosystems Clone Id: YLR138W Accession: YLR138W
YSC4515-98810980 Yeast GST-Tagged Strain Open Biosystems Clone Id:
YLL010C Accession: YLL010C YSC4515-98807049 Yeast GST-Tagged Strain
Open Biosystems Clone Id: YJL124C Accession: YJL124C
YSC4515-98805426 Yeast GST-Tagged Strain Open Biosystems Clone Id:
YCR020C-A Accession: YCR020C-A YSC4515-98809076 Yeast GST-Tagged
Strain Open Biosystems Clone Id: YEL015W Accession: YEL015W
YSC4515-98808930 Yeast GST-Tagged Strain Open Biosystems Clone Id:
YPR129W Accession: YPR129W YSC4515-98806813 Yeast GST-Tagged Strain
Open Biosystems Clone Id: YHR121W Accession: YHR121W
YSC4515-98811389 Yeast GST-Tagged Strain Open Biosystems Clone Id:
YDR378C Accession: YDR378C YSC4515-98805850 Yeast GST-Tagged Strain
Open Biosystems Clone Id: YDR259C Accession: YDR259C Plasmids
pKNOCK-Km Km.sup.r, mob, broad host range cloning vector, 1.8 kb
Alexeyev (1999) pET-DEST42 Ap.sup.r, Cm.sup.r, C-terminal 6xHis and
V5 epitope Invitrogen pBBR1MCS-3 Tc.sup.r, mob, broad host range
cloning vector pBBR3DEST42 Cm.sup.rTc.sup.r, C-terminal 6xHis and
V5 epitope This application pDONR221 Km.sup.r, gateway entry vector
Gm.sup.r, N-terminal GST Invitrogen p42-0347 pBBR3DEST42 containing
ZM4 ZMO0347 This application Primers hfq_MF cggagagatggtcagtcaca
(SEQ ID NO: 51) 262-bp hfq_MR ttcttgctgctgcataatcg (SEQ ID NO: 52)
hfq_CF atggccgaaaaggtcaacaa (SEQ ID NO: 53) 483-bp hfq_CR
tcaatcctcgtctcgccttt (SEQ ID NO: 54) hfq_OCF
caaagcttgagctcgaattcatttttgccgtggtagttgc (SEQ ID NO: 55) 1050-bp
hfq_OCR caggtacctctagaattcaccactcaatcctcgtctcg (SEQ ID NO: 56)
Example 2
[0077] This example describes the results of the experiments
showing that overexpression of the Zymomonas mobilis global
regulator gene hfq confers enhanced tolerance to sodium
acetate.
[0078] The Z. mobilis hfq gene (SEQ ID NO: 1) was cloned into the
vector pBBR3-DEST42 (FIG. 2A) and the resulting plasmid construct
p42-0347 was transformed into the wild-type strain ZM4 and acetate
mutant AcR through conjugation. In addition, an insertional mutant
of Z. mobilis strain AcR hfq gene (ZMO0347) was created using the
pKNOCK system (Brown 2006; Alexeyev 1999) and complemented with
plasmid p42-0347. The hfq gene and the primer positions used for
mutant construction and hfq gene over-expression are shown in FIG.
2B. An insertional mutant of hfq (ZMO0347) was generated in the AcR
background and designated as strain "AcRIM0347". The hfq gene was
over-expressed via plasmid p42-0347 in both wild-type ZM4 and the
acetate mutant AcR backgrounds, their susceptibilities to sodium
acetate and other stressors were tested in growth assays along with
strains ZM4 and AcR. The AcR acetate tolerant mutant is more
tolerant to sodium acetate than its wild-type ZM4 parental strain
(Joachimstahl et al. 1998); however, the insertional inactivation
of the hfq gene in AcR reduces its sodium acetate tolerance (FIGS.
3A-3C). These strains were tested for their growth responses in
four different concentrations of sodium acetate: 0, 12 g/L, 16 g/L
(195 mM) and 20 g/L (FIGS. 3A-3C).
[0079] The sum of these data show that hfq expression contributed
to sodium acetate tolerance. The AcRIM0347 mutant strain grew
slightly more slowly in RM medium compared to the parental strain,
i.e., in the absence of the sodium acetate stressor (FIG. 3A).
Strains ZM4 and AcR with intact hfq genes grew faster than the hfq
mutant AcRIM0347 strain in the presence of 12 g/L sodium acetate
(FIG. 3B). The AcRIM0347 mutant phenotype was mostly restored by
hfq expression and complementation via plasmid p42-0347. Similar,
but more dramatic growth phenotypes were observed for sodium
acetate of 16 g/L with the wild-type strain unable to grow at this
concentration (FIG. 3C).
Example 3
[0080] This example describes the experiments performed to compare
the negative effects of pretreatment inhibitors on Z. mobilis
growth, and to demonstrate that Hfq overexpression confers
tolerance to pretreatment inhibitors.
[0081] Pretreatment Inhibitors had Negative Effects on Z. mobilis
Growth
[0082] The growth of Z. mobilis strains was reduced in the presence
of acetate, vanillin, furfural, or HMF with increased lag phases
and/or slower growth rates and/or final bacterial cell densities
depending on the respective condition and strain (Tables 3-4; FIGS.
4A-4E and 5A-5E). Among the different forms of acetate counter-ions
tested, sodium acetate had the most significant inhibitory effect
on wild-type Z. mobilis growth. This was followed by potassium
acetate and ammonium acetate, and sodium chloride had the least
negative influence on wild-type Z. mobilis growth (Table 3; FIGS.
4A-4E). Wild-type ZM4 growth was completely inhibited when RM
medium was supplemented with 195 mM sodium acetate (Table 3; FIG.
4C). Among the pretreatment inhibitors of vanillin, furfural, and
HMF, vanillin had the most significant inhibitory effect on Z.
mobilis, while HMF had the least effect (Table 4). It took Z.
mobilis a longer period of time to complete active growth and reach
the stationary phase, which was about 16, 19 or 21 h in the
presence of HMF, furfural or vanillin, respectively, as compared to
11 h without any inhibitor present in the medium (FIGS. 5A-5D).
TABLE-US-00003 TABLE 3 Growth rate and final cell density of
different Z. mobilis strains in the absence or presence of
different sodium and acetate ions. AcRIM0347 ZM4 ZM4 AcR AcRIM0347
(p42-0347) (p42-0347) Growth RM 0.42 .+-. 0.01 0.39 .+-. 0.01 0.32
.+-. 0.003 0.33 .+-. 0.002 0.38 .+-. 0.003 rate RM (NaCl) 0.24 .+-.
0.008 0.29 .+-. 0.005 0.21 .+-. 0.008 0.22 .+-. 0.009 0.25 .+-.
0.008 (hour.sup.-1) RM (NH.sub.4OAc) 0.20 .+-. 0.008 0.19 .+-.
0.005 NA 0.22 .+-. 0.002 0.19 .+-. 0.007 RM (Kac) 0.15 .+-. 0.004
0.12 .+-. 0.000 NA 0.09 .+-. 0.003 0.12 .+-. 0.006 RM (NaAc) NA
0.29 .+-. 0.04 0.12 .+-. 0.004 0.16 .+-. 0.002 0.27 .+-. 0.004
Final RM 0.95 .+-. 0.006 1.01 .+-. 0.006 0.94 .+-. 0.004 0.92 .+-.
0.002 1.02 .+-. 0.004 Cell RM (NaCl) 0.73 .+-. 0.01 0.96 .+-. 0.01
0.73 .+-. 0.03 0.72 .+-. 0.02 0.84 .+-. 0.01 Density RM
(NH.sub.4OAc) 0.43 .+-. 0.01 0.42 .+-. 0.006 NA 0.32 .+-. 0.007
0.37 .+-. 0.008 (OD.sub.600 nm) RM (Kac) 0.42 .+-. 0.002 0.40 .+-.
0.000 NA 0.28 .+-. 0.007 0.34 .+-. 0.004 RM (NaAc) NA 0.63 .+-.
0.02 0.25 .+-. 0.001 0.45 .+-. 0.002 0.59 .+-. 0.002 "NA" indicates
that the data are not available due to the lack of growth in that
condition. The concentration for all the chemicals (NaCl,
NH.sub.4OAc, KAc, NaAc) supplemented into the RM is 195 mM. NaCl:
sodium chloride, NH.sub.4OAc: ammonium acetate, KAc: potassium
acetate, NaAc: sodium acetate. Strains included in this study are:
ZM4: Zymomonas mobilis ZM4 wild-type; AcR: ZM4 acetate tolerant
mutant; ZM4 (p42-0347): ZM4 containing a gateway plasmid p42-0347
to express ZM4 gene ZMO0347; AcRIM0347: AcR insertional mutant of
ZMO0347; AcRIM0347 (p42-0347): AcRIM0347 containing gateway plasmid
p42-0347. This experiment has been repeated at least three times
with similar result. Duplicate biological replicates were used for
each condition.
TABLE-US-00004 TABLE 4 Growth rate and final cell density of
different Z. mobilis strains in the absence or presence of
different pretreatment inhibitors. AcRIM0347 ZM4 AcR AcRIM0347
(p42-0347) Growth RM 0.48 .+-. 0.03 0.46 .+-. 0.003 0.35 .+-. 0.004
0.32 .+-. 0.003 rate HMF 0.36 .+-. 0.02 0.35 .+-. 0.01 0.19 .+-.
0.02 0.22 .+-. 0.001 (hour.sup.-1) Furfural 0.31 .+-. 0.01 0.30
.+-. 0.005 0.19 .+-. 0.03 0.20 .+-. 0.01 Vanillin 0.26 .+-. 0.001
0.26 .+-. 0.01 0.20 .+-. 0.006 0.20 .+-. 0.003 Final RM 0.91 .+-.
0.01 0.98 .+-. 0.006 0.95 .+-. 0.003 0.92 .+-. 0.006 Cell HMF 0.93
.+-. 0.003 0.96 .+-. 0.006 0.67 .+-. 0.03 0.78 .+-. 0.02 Density
Furfural 0.88 .+-. 0.006 0.89 .+-. 0.009 0.67 .+-. 0.001 0.80 .+-.
0.02 (OD.sub.600 nm) Vanillin 0.69 .+-. 0.006 0.71 .+-. 0.01 0.66
.+-. 0.01 0.70 .+-. 0.01 The concentration for the inhibitor
supplemented into the RM is: HMF: 0.75 g/L, furfural, or vanillin:
1 g/L. Strains included in this study are: ZM4: Zymomonas mobilis
ZM4 wild-type; AcR: ZM4 acetate tolerant mutant; AcRIM0347: AcR
insertional mutant of ZMO0347; AcRIM0347 (p42-0347): AcRIM0347
containing gateway plasmid p42-0347. This experiment has been
repeated at least three times with similar result. Duplicate
biological replicates were used for each condition.
[0083] Hfq Contributes to Sodium and Acetate Ion Tolerances
[0084] Although the final cell density of hfq mutant AcRIM0347 was
similar to that of AcR parental strain (Table 3; FIG. 5A), the
growth rate of AcRIM0347 was reduced by about one-fifth even
without any inhibitor in the RM, indicating that hfq plays a
central role in normal Z. mobilis physiology. Wild-type ZM4 that
contained p42-0347 was able to grow in the presence of 195 mM
sodium acetate and had a similar growth rate and final cell density
to that of acetate tolerant strain AcR (Table 3; FIG. 4C). The
wild-type ZM4 was unable to grow under this condition.
[0085] The inactivation of the hfq gene in AcR decreased this
acetate tolerant strain's resistance to both sodium ion (sodium
chloride) and acetate ion (ammonium acetate and potassium acetate)
(Table 3; FIGS. 4A-4E). hfq mutant AcRIM0347 was unable to grow in
the presence of 195 mM ammonium acetate or potassium acetate (Table
3; FIGS. 4D-4E). Both the growth rate and final cell density of hfq
mutant AcRIM0347 were reduced by at least a quarter in the presence
of 195 mM sodium chloride, and about 60% in the presence of 195 mM
sodium acetate compared to that of the parental strain AcR (Table
3; FIGS. 4B-4C). The AcRIM0347 hfq mutation was complemented by the
introduction of an hfq-expressing plasmid (p42-0347) into the
strain. The complemented mutant strain recovered at least half of
the parental strains growth rate and 70% of its final cell density
in the presence of 195 mM acetate ion (whether as sodium, ammonium
or potassium acetate) (Table 3; FIGS. 4A-4E).
[0086] Hfq Contributes to Vanillin, Furfural, HMF and
H.sub.2O.sub.2 Tolerances
[0087] AcRIM0347 growth rates were lower than that of ZM4 and AcR
under all conditions tests, except for growth in RM broth (Table 4;
FIGS. 5A-5D). AcRIM0347 also achieved lower final cell densities
compared to ZM4 and AcR (Table 4; FIGS. 5A-5D). When AcRIM0347 was
provided functional Z. mobilis Hfq via p42-0347, growth rates under
all conditions were largely unchanged (Table 4). However, shorter
lag phases were observed for AcRIM0347 (p42-0347) grown with
vanillin, furfural or HMF and increases in final cell densities
were also observed under these conditions (Table 4; FIGS. 5A-5D).
These data indicate that hfq is important for optimal Z. mobilis
growth and its ability to resist furfural, HMF and vanillin
toxicity.
[0088] Hfq also contributed to tolerance of other stress such as
the reactive oxidative species generating hydrogen peroxide
(H.sub.2O.sub.2). hfq mutant AcRIM0347 was sensitive to hydrogen
peroxide H.sub.2O.sub.2 and no observable growth was detected in RM
medium with 0.001% H.sub.2O.sub.2 (FIG. 5E). The wild-type strain
ZM4 and acetate tolerant strain AcR grew well at this
concentration. Complementation of the hfq mutant strain allowed
strain AcRIM0347(p42-0347) to grow in RM medium with 0.001%
H.sub.2O.sub.2.
Example 4
[0089] This Example describes experiments to show that Yeast Lsm
proteins contribute to pretreatment inhibitor tolerance.
[0090] Lsm Protein and Yeast Tolerance to Sodium and Acetate
Ions
[0091] S. cerevisiae Sm and Sm-like (Lsm) proteins are similar to
Z. mobilis Hfq at the level of protein sequence. Growth of yeast
Lsm deletion mutants and Lsm over-expressing strains in 305 mM
ammonium acetate, potassium acetate, or sodium acetate was assessed
to test whether S. cerevisiae Lsm proteins and ZM4 Hfq had
functionally similar roles.
[0092] Deletion of seven Lsm genes affecting three Lsm
heteroheptameric ring components (Lsm1, Lsm6, Lsm7) and four other
Lsm proteins containing an Sm domain (Lsm9, Lsm12, Lsm13, Lsm16),
was shown to have negative effects on the growth of S. cerevisiae
in the presence of sodium acetate 40 g/L (FIG. 6A). On the other
hand, six Lsm protein over-expressing S. cerevisiae strains (Lsm1,
Lsm6, Lsm9, Lsm12, Lsm13, Lsm16) displayed enhanced growth in the
presence of sodium acetate 40 g/L (FIG. 6B).
[0093] Growth differences between the Lsm mutants and yeast
wild-type BY4741 in the CM broth without the addition of acetate or
with 305 mM NaCl were not observed (FIGS. 7A-7B, respectively). S.
cerevisiae Lsm proteins involved in RNA processing ring complex
formation (Lsm1, 6, 7), especially Lsm6, played a role in acetate
tolerance (FIGS. 7C-7E, 7K-7M). Lsm protein deletion mutants Lsm1,
6, and 7 showed decreased acetate tolerance compared to the
wild-type control strain, especially in early growth stages for
acetate with sodium, ammonium and potassium counter-ions (FIGS.
7C-7E). The Lsm overexpression strains grew similarly to wild-type
BY4741 without the addition of acetate or with 305 mM NaCl (FIGS.
7I, 7J), but each of the Lsm protein overexpression strains showed
enhanced acetate tolerance compared to the wild-type strain with
sodium, ammonium or potassium counter-ions (FIGS. 7K-7M).
[0094] Lsm Proteins and Yeast Tolerance to Vanillin, Furfural and
HMF
[0095] The effect of Lsm proteins on S. cerevisiae tolerance to
pretreatment inhibitors vanillin, furfural, and HMF was also
investigated using the seven Lsm deletion mutants and six Lsm
overexpression strains described above. Each yeast deletion mutant
and each overexpression strain showed similar growth profiles
compared to wild-type strain BY4741 in the absence of inhibitors
(FIGS. 7A; 7I). Deletion mutants for Lsm1, 6 and 7 proteins were
unable to grow or showed extended lag phases before recovery from
the inhibitory effects of pretreatment inhibitors (FIGS. 7F-7H).
Overexpression of Lsm proteins provided a slight growth advantage
in the presence of 1.5 g/L HMF and furfural (FIGS. 7O-7P). However,
a detrimental effect on growth was observed for overexpression
strains when cultured in the presence of 0.75 g/L vanillin (FIG.
7N). The data indicated that Lsm proteins Lsm1, 6, and 7 especially
Lsm6, which are the components of yeast RNA processing ring
complex, play a role in tolerance to the model inhibitors used in
this study.
REFERENCES
[0096] Alexeyev M F: The pKNOCK series of broad-host-range
mobilizable suicide vectors for gene knockout and targeted DNA
insertion into the chromosome of gram-negative bacteria.
BioTechniques 1999, 26(5):824-826, 828. [0097] Almeida J R M, Modig
T, Petersson A, Hahn-Hagerdal B, Liden G, Gorwa-Grauslund M F:
Increased tolerance and conversion of inhibitors in lignocellulosic
hydrolysates by Saccharomyces cerevisiae. J Chem Technol Biotechnol
2007, 82(4):340-349. [0098] Amberg D C, Burke D J, Strathern J N:
Methods in Yeast Genetics: A Cold Spring Harbor Laboratory Course
Manual. New York: Cold Spring Harbor Press; 2005. [0099] Baumler D
J, Hung K F, Bose J L, Vykhodets B M, Cheng C M, Jeong K C, Kaspar
C W: Enhancement of acid tolerance in Zymomonas mobilis by a
proton-buffering peptide. Appl Biochem Biotechnol 2006,
134(1):15-26. [0100] Brown S D: Analysis of a 16 kb region of the
Mesorhizobium loti R7A symbiosis island encoding bio and nad loci
and a novel member of the lad family Dunedin: University of Otago;
2002. [0101] Brown S D, Martin M, Deshpande S, Seal S, Huang K, Alm
E, Yang Y, Wu L, Yan T, Liu X et al: Cellular response of
Shewanella oneidensis to strontium stress. Appl Environ Microbiol
2006, 72(1):890-900. [0102] Chinnawirotpisan P, Theeragool G,
Limtong S, Toyama H, Adachi O O, Matsushita K: Quinoprotein alcohol
dehydrogenase is involved in catabolic acetate production, while
NAD-dependent alcohol dehydrogenase in ethanol assimilation in
Acetobacter pasteurianus SKU1108. J Biosci Bioeng. 2003;
96(6):564-71. [0103] Deanda K, Zhang M, Eddy C, Picataggio S:
Development of an arabinose-fermenting Zymomonas mobilis strain by
metabolic pathway engineering. Appl Environ Microbiol 1996,
62(12):4465-4470. [0104] Dien B S, Cotta M A, Jeffries T W:
Bacteria engineered for fuel ethanol production: current status.
Appl Microbiol Biotechnol 2003, 63(3):258-266. [0105] Fukaya M,
Takemura H, Okumura H, Kawamura Y, Horinouchi S, Beppu T: Cloning
of genes responsible for acetic acid resistance in Acetobacter
aceti. J Bacteriol 1990, 172(4):2096-2104. [0106] Fukaya M,
Takemura H, Tayama K, Okumura H, Kawamura Y, Horinouchi S, Beppu T:
The aarC gene responsible for acetic acid assimilation confers
acetic acid resistance on Acetobacter aceti. J Ferment Bioeng 1993,
76(4):270-275. [0107] Gunasekaran P, Raj K C: Ethanol fermentation
technology--Zymomonas mobilis. Current Science 1999, 77(1):56-68.
[0108] Guisbert E. et al., "Hfq the .sigma..sup.E-Mediated Envelope
Stress Response and the .sigma..sup.32-Mediated Cytoplasmic Stress
Response in Escherichia coli.sup..gradient.", J Bacteriol 2007
189(5): 1963-1973. [0109] Hermann et al., EMBO J 14: 2976-2088
(1995). [0110] Jeon Y J, Svenson C J, Joachimsthal E L, Rogers P L:
Kinetic analysis of ethanol production by an acetate-resistant
strain of recombinant Zymomonas mobilis. Biotechnol Lett 2002,
24(10):819-824. [0111] Joachimstahl E, Haggett K D, Jang J H,
Rogers P L: A mutant of Zymomonas mobilis ZM4 capable of ethanol
production from glucose in the presence of high acetate
concentrations. Biotechnol Lett 1998, 20(2):137-142. [0112]
Joachimsthal E L, Rogers P L: Characterization of a
high-productivity recombinant strain of Zymomonas mobilis for
ethanol production from glucose/xylose mixtures. Appl Biochem
Biotechnol 2000, 84-6:343-356. [0113] Kadar Z, Maltha S F, Szengyel
Z, Reczey K, De Laat W: Ethanol fermentation of various pretreated
and hydrolyzed substrates at low initial pH. Appl Biochem
Biotechnol 2007, 137:847-858. [0114] Kalogeraki V S, Winans S C:
Suicide plasmids containing promoterless reporter genes can
simultaneously disrupt and create fusions to target genes of
diverse bacteria. Gene 1997, 188(1):69-75. [0115] Koch B, Jensen L
E, Nybroe O: A panel of Tn7-based vectors for insertion of the gfp
marker gene or for delivery of cloned DNA into Gram-negative
bacteria at a neutral chromosomal site. J Microbiol Meth 2001,
45(3):187-195. [0116] Lawford H G, Rousseau J D: Effects of pH and
acetic acid on glucose and xylose metabolism by a genetically
engineered ethanologenic Escherichia coli. Appl Biochem Biotechnol
1993, 39:301-322. [0117] Lawford H G, Rousseau J D: Improving
fermentation performance of recombinant Zymomonas in acetic
acid-containing media. Appl Biochem Biotechnol 1998, 70-2:161-172.
[0118] Lawford H G, Rousseau J D, Mohagheghi A, McMillan J D:
Fermentation performance characteristics of a
prehydrolyzate-adapted xylose-fermenting recombinant Zymomonas in
batch and continuous fermentations. Appl Biochem Biotechnol 1999,
77-9:191-204. [0119] Lawford H G, Rousseau J D, Tolan J S:
Comparative ethanol productivities of different Zymomonas
recombinants fermenting oat hull hydrolysate. Appl Biochem
Biotechnol 2001, 91-3:133-146. [0120] Lawford H G, Rousseau J D:
Fermentation performance assessment of a genomically integrated
xylose-utilizing recombinant of Zymomonas mobilis 39676. Appl
Biochem Biotechnol 2001, 91-3:117-131. [0121] Lawford H G, Rousseau
J D: Cellulosic fuel ethanol--Alternative fermentation process
designs with wild-type and recombinant Zymomonas mobilis. Appl
Biochem Biotechnol 2003, 105:457-469. [0122] Matsushita K, Inoue T,
Adachi O, Toyama H: Acetobacter aceti possesses a proton motive
force-dependent efflux system for acetic acid. J Bacteriol 2005,
187(13):4346-4352. [0123] McMillan J D: Conversion of hemicellulose
hydrolyzates to ethanol. In: Enzymatic Conversion of Biomass for
Fuels Production. Edited by Himmel MEBJOORP, vol. 566; 1994:
411-437. [0124] Mohagheghi A, Evans K, Chou Y C, Zhang M:
Cofermentation of glucose, xylose, and arabinose by genomic
DNA-integrated xylose/arabinose fermenting strain of Zymomonas
mobilis AX101. Appl Biochem Biotechnol 2002, 98-100:885-898. [0125]
Mohagheghi A, Dowe N, Schell D, Chou Y C, Eddy C, Zhang M:
Performance of a newly developed integrant of Zymomonas mobilis for
ethanol production on corn stover hydrolysate. Biotechnol Lett
2004, 26(4):321-325. [0126] Mullins E A, Francois J A, Kappock T J:
A specialized citric acid cycle requiring succinyl-coenzyme A
(CoA): Acetate CoA-transferase (AarC) confers acetic acid
resistance on the acidophile Acetobacter aceti. J Bacteriol 2008,
190(14):4933-4940. [0127] Okumura H, Uozumi T, Beppu T: Biochemical
characteristics of spontaneous mutants of Acetobacter aceti
deficient in ethanol oxidation. Agri Biological Chem 1985,
49(8):2485-2487. [0128] Panesar P S, Marwaha S S, Kennedy J F:
Zymomonas mobilis: an alternative ethanol producer. J Chem Technol
Biotechnol 2006, 81(4):623-635. [0129] Pecota D C, Kim C S, Wu K W,
Gerdes K, Wood T K: Combining the hok/sok, parDE, and pnd
postsegregational killer loci to enhance plasmid stability. Appl
Environ Microbiol 1997, 63(5):1917-1924. [0130] Pelletier et al. "A
general system for studying protein-protein interactions in
gram-negative bacteria", J. Proteome Research 2008, 7(8):3319-3328.
[0131] Ranatunga T D, Jervis J, Helm R F, McMillan J D, Hatzis C:
Identification of inhibitory components toxic toward Zymomonas
mobilis CP4(pZB5) xylose fermentation. Appl Biochem Biotechnol
1997, 67(3):185-198. [0132] Rogers P L, Goodman A E, Heyes R H:
Zymomonas ethanol fermentations. Microbiol Sci 1984, 1(6):133-136.
[0133] Rogers P L, Jeon Y J, Lee K J, Lawford H G: Zymomonas
mobilis for fuel ethanol and higher value products. In: Biofuels.
vol. 108; 2007: 263-288. [0134] Steiner P, Sauer U: Overexpression
of the ATP-dependent helicase RecG improves resistance to weak
organic acids in Escherichia coli. Appl Microbiol Biotechnol 2003,
63(3):293-299. [0135] Swings J, De Ley J: The biology of Zymomonas
mobilis. Bacteriol Rev 1977, 41:1-46. [0136] Takahashi C M,
Takahashi D F, Carvalhal M L C, Alterthum F: Effects of acetate on
the growth and fermentation performance of Escherichia coli KO11.
Appl Biochem Biotechnol 1999, 81(3):193-203. [0137] Takemura H,
Horinouchi S, Beppu T: Novel insertion sequence IS1380 from
Acetobacter pasteurianus is involved in loss of ethanol oxidizing
ability. J Bacteriol 1991, 173(22):7070-7076. [0138] Tiffany
Ho-Ching et al., "Characterization of broadly pleiotropic
phenotypes caused by an hfq insertion mutation in Escherichia coli
K-12", Mol Microbiol 1994 13(1): 35-49. [0139] Tsui H C, Leung H C,
Winkler M E.: Characterization of broadly pleiotropic phenotypes
caused by an hfq insertion mutation in Escherichia coli K-12. Mol
Microbiol. 1994 July; 13(1):35-49. [0140] Valentin-Hansen et al.
"The bacterial Sm-like protein Hfq: a key player in RNA
transactions", Mol Microbiol 2004, 51(6): 1525-1533. [0141] Yang S,
Tschaplinski T J, Engle N L, Carroll S L, Martin S L, Davison B H,
Palumbo A V, Rodriguez M Jr, Brown S D: Transcriptomic and
metabolomic profiling of Zymomonas mobilis during aerobic and
anaerobic fermentations. BMC Genomics. 2009 Jan. 20; 10:34. [0142]
Zhang A. et al., "The Sm-like Hfq Protein Increases OxyS RNA
Interaction with Target mRNAs", Mol Cell 2002 9: 11-22. [0143]
Zhang A. et al., "Global analysis of small RNA and mRNA targets of
Hfq", Mol Microbiol 2003, 50(4): 1111-1124. [0144] Zhang M, Eddy C,
Deanda K, Finkestein M, Picataggio S: Metabolic engineering of a
pentose metabolism pathway in ethanologenic Zymomonas mobilis.
Science 1995, 267(5195):240-243.
Sequence CWU 1
1
561486DNAZymomonas mobilis 1atggccgaaa aggtcaacaa tcttcaggat
tttttcctta ataccttgcg caagacccgc 60acaccggtga cgatgttttt ggtaaaaggt
gtcaaattac agggcgttat cacctggttt 120gacaattttt ctattctgct
gcggagagat ggtcagtcac agctggtcta taaacacgct 180atttctacca
ttattccggc gcatccgctg gaacagctgc gcgaaagccg cagtttgatg
240gctgaacgta aatccagttt gcttcaggat gtctttttat cggcgattat
gcagcagcaa 300gaaccggtga caatgttttt gataaacggg gtcatgttgc
aaggtgaaat tgccgccttc 360gatttattct gcgtcttgtt gacccgtaat
gacgacgcgc agctggttta taaacatgcg 420gtttcaacag tgcagcctgt
gaaatctgta gatttgacaa tgacagaaag gcgagacgag 480gattga
4862161PRTZymomonas mobilis 2Met Ala Glu Lys Val Asn Asn Leu Gln
Asp Phe Phe Leu Asn Thr Leu1 5 10 15Arg Lys Thr Arg Thr Pro Val Thr
Met Phe Leu Val Lys Gly Val Lys 20 25 30Leu Gln Gly Val Ile Thr Trp
Phe Asp Asn Phe Ser Ile Leu Leu Arg 35 40 45Arg Asp Gly Gln Ser Gln
Leu Val Tyr Lys His Ala Ile Ser Thr Ile 50 55 60Ile Pro Ala His Pro
Leu Glu Gln Leu Arg Glu Ser Arg Ser Leu Met65 70 75 80Ala Glu Arg
Lys Ser Ser Leu Leu Gln Asp Val Phe Leu Ser Ala Ile 85 90 95Met Gln
Gln Gln Glu Pro Val Thr Met Phe Leu Ile Asn Gly Val Met 100 105
110Leu Gln Gly Glu Ile Ala Ala Phe Asp Leu Phe Cys Val Leu Leu Thr
115 120 125Arg Asn Asp Asp Ala Gln Leu Val Tyr Lys His Ala Val Ser
Thr Val 130 135 140Gln Pro Val Lys Ser Val Asp Leu Thr Met Thr Glu
Arg Arg Asp Glu145 150 155 160Asp3309DNAEscherichia coli
3atggctaagg ggcaatcttt acaagatccg ttcctgaacg cactgcgtcg ggaacgtgtt
60ccagtttcta tttatttggt gaatggtatt aagctgcaag ggcaaatcga gtcttttgat
120cagttcgtga tcctgttgaa aaacacggtc agccagatgg tttacaagca
cgcgatttct 180actgttgtcc cgtctcgccc ggtttctcat cacagtaaca
acgccggtgg cggtaccagc 240agtaactacc atcatggtag cagcgcgcag
aatacttccg cgcaacagga cagcgaagaa 300accgaataa 3094102PRTEscherichia
coli 4Met Ala Lys Gly Gln Ser Leu Gln Asp Pro Phe Leu Asn Ala Leu
Arg1 5 10 15Arg Glu Arg Val Pro Val Ser Ile Tyr Leu Val Asn Gly Ile
Lys Leu 20 25 30Gln Gly Gln Ile Glu Ser Phe Asp Gln Phe Val Ile Leu
Leu Lys Asn 35 40 45Thr Val Ser Gln Met Val Tyr Lys His Ala Ile Ser
Thr Val Val Pro 50 55 60Ser Arg Pro Val Ser His His Ser Asn Asn Ala
Gly Gly Gly Thr Ser65 70 75 80Ser Asn Tyr His His Gly Ser Ser Ala
Gln Asn Thr Ser Ala Gln Gln 85 90 95Asp Ser Glu Glu Thr Glu
1005249DNAClostridium thermoalcaliphilum 5gtggtgagca aaaataatat
taatttacag gacgtttttc taaaccaggt aagaaaagaa 60catattccgg ttactgttta
tcttaccaac ggattccagt taaaaggaac ggtaaaggga 120tttgacaatt
ttaccgttgt gcttgacagt gagggaaggc agcagctgat ttataaacat
180gcaatttcaa caataagccc catgaaaatt gttagcttga ttttcaacga
caataacaga 240tcggaataa 249682PRTClostridium thermoalcaliphilum
6Met Val Ser Lys Asn Asn Ile Asn Leu Gln Asp Val Phe Leu Asn Gln1 5
10 15Val Arg Lys Glu His Ile Pro Val Thr Val Tyr Leu Thr Asn Gly
Phe 20 25 30Gln Leu Lys Gly Thr Val Lys Gly Phe Asp Asn Phe Thr Val
Val Leu 35 40 45Asp Ser Glu Gly Arg Gln Gln Leu Ile Tyr Lys His Ala
Ile Ser Thr 50 55 60Ile Ser Pro Met Lys Ile Val Ser Leu Ile Phe Asn
Asp Asn Asn Arg65 70 75 80Ser Glu7279DNAAnaerocellum thermophilum
7gtggcgaaag gaagtttaaa cttgcaggac ttatttttaa atcagttaag aaaagaaaaa
60gtgaatgtta caatttttct gctcagcggt tttcagttaa aaggagttat caagggtttt
120gataacttta cattgattgt agagactgac aataacaagc agcaactaat
ttacaagcac 180gctatatctt caatcatgcc ctcaaagcca ataaactata
tggctcaggc acagaataat 240caacaagctt ctcaacaatc aaataataat caaggttaa
279892PRTAnaerocellum thermophilum 8Met Ala Lys Gly Ser Leu Asn Leu
Gln Asp Leu Phe Leu Asn Gln Leu1 5 10 15Arg Lys Glu Lys Val Asn Val
Thr Ile Phe Leu Leu Ser Gly Phe Gln 20 25 30Leu Lys Gly Val Ile Lys
Gly Phe Asp Asn Phe Thr Leu Ile Val Glu 35 40 45Thr Asp Asn Asn Lys
Gln Gln Leu Ile Tyr Lys His Ala Ile Ser Ser 50 55 60Ile Met Pro Ser
Lys Pro Ile Asn Tyr Met Ala Gln Ala Gln Asn Asn65 70 75 80Gln Gln
Ala Ser Gln Gln Ser Asn Asn Asn Gln Gly 85
909300DNACaldicellulosiruptor saccharolyticus 9gtggcaaaag
gaaatttgaa cttgcaggat ttatttttaa accagcttcg aaaagaaaaa 60gtcaacgtta
caatcttttt actgagcgga ttccaattga aaggagttat caaaggtttt
120gataacttta cattggtggt agagacagaa aataacaaac agcagctcat
ttacaaacat 180gcaatttctt ctattctacc atcaaagcca ataaactaca
tggctcaagt tcaaaactca 240caagtgcaaa acacagcttc tcagcaaagt
aacaataacc aaaatcaaga gtcaaaataa 3001099PRTCaldicellulosiruptor
saccharolyticus 10Val Ala Lys Gly Asn Leu Asn Leu Gln Asp Leu Phe
Leu Asn Gln Leu1 5 10 15Arg Lys Glu Lys Val Asn Val Thr Ile Phe Leu
Leu Ser Gly Phe Gln 20 25 30Leu Lys Gly Val Ile Lys Gly Phe Asp Asn
Phe Thr Leu Val Val Glu 35 40 45Thr Glu Asn Asn Lys Gln Gln Leu Ile
Tyr Lys His Ala Ile Ser Ser 50 55 60Ile Leu Pro Ser Lys Pro Ile Asn
Tyr Met Ala Gln Val Gln Asn Ser65 70 75 80Gln Val Gln Asn Thr Ala
Ser Gln Gln Ser Asn Asn Asn Gln Asn Gln 85 90 95Glu Ser
Lys11261DNAThermoanaerobacter sp. 11atggcaagtt caaaagcagc
tattaattta caggatatct ttttaaatca agtgaggaaa 60gagcatgtac cagtaactgt
ctacttaatc aacggatttc aattaaaggg tttagtgaaa 120ggatttgata
attttacagt ggtgttggag tcagagaaca aacagcaact tcttatctac
180aaacatgcta tttcgacaat tacacctcaa aagcctgtga tcttctctgc
ttctgataaa 240gatgagaaga gagaagagtg a 2611286PRTThermoanaerobacter
sp. 12Met Ala Ser Ser Lys Ala Ala Ile Asn Leu Gln Asp Ile Phe Leu
Asn1 5 10 15Gln Val Arg Lys Glu His Val Pro Val Thr Val Tyr Leu Ile
Asn Gly 20 25 30Phe Gln Leu Lys Gly Leu Val Lys Gly Phe Asp Asn Phe
Thr Val Val 35 40 45Leu Glu Ser Glu Asn Lys Gln Gln Leu Leu Ile Tyr
Lys His Ala Ile 50 55 60Ser Thr Ile Thr Pro Gln Lys Pro Val Ile Phe
Ser Ala Ser Asp Lys65 70 75 80Asp Glu Lys Arg Glu Glu
8513591DNASaccharomyces cerevisiae 13atgagcaaaa tacaggtggc
acatagcagc cgactagcca accttattga ttataagctg 60agggttctca ctcaagatgg
ccgcgtttac atcgggcaat tgatggcatt tgataaacat 120atgaatttag
tgttgaatga gtgtatagaa gagagggtac ccaaaactca actagataaa
180ttaagaccga gaaaagattc aaaagatgga accactttga acatcaaggt
agaaaaaaga 240gtgttgggac tgactatact aagaggagaa cagatcttat
ccacagtggt ggaggataag 300ccgctactat ccaagaagga aagactagtg
agagataaaa aggaaaagaa acaagcgcaa 360aagcagacga aactaagaaa
agagaaagag aaaaagccgg gaaagatcgc taaacctaac 420acggccaatg
cgaagcatac tagtagcaat tctagggaga ttgcccaacc atcgtcgagc
480agatacaatg gtggcaacga taatatcggc gcaaataggt cgaggtttaa
taatgaagcg 540ccccctcaaa caaggaagtt tcagccccca ccaggtttta
aaagaaaata a 59114196PRTSaccharomyces cerevisiae 14Met Ser Lys Ile
Gln Val Ala His Ser Ser Arg Leu Ala Asn Leu Ile1 5 10 15Asp Tyr Lys
Leu Arg Val Leu Thr Gln Asp Gly Arg Val Tyr Ile Gly 20 25 30Gln Leu
Met Ala Phe Asp Lys His Met Asn Leu Val Leu Asn Glu Cys 35 40 45Ile
Glu Glu Arg Val Pro Lys Thr Gln Leu Asp Lys Leu Arg Pro Arg 50 55
60Lys Asp Ser Lys Asp Gly Thr Thr Leu Asn Ile Lys Val Glu Lys Arg65
70 75 80Val Leu Gly Leu Thr Ile Leu Arg Gly Glu Gln Ile Leu Ser Thr
Val 85 90 95Val Glu Asp Lys Pro Leu Leu Ser Lys Lys Glu Arg Leu Val
Arg Asp 100 105 110Lys Lys Glu Lys Lys Gln Ala Gln Lys Gln Thr Lys
Leu Arg Lys Glu 115 120 125Lys Glu Lys Lys Pro Gly Lys Ile Ala Lys
Pro Asn Thr Ala Asn Ala 130 135 140Lys His Thr Ser Ser Asn Ser Arg
Glu Ile Ala Gln Pro Ser Ser Ser145 150 155 160Arg Tyr Asn Gly Gly
Asn Asp Asn Ile Gly Ala Asn Arg Ser Arg Phe 165 170 175Asn Asn Glu
Ala Pro Pro Gln Thr Arg Lys Phe Gln Pro Pro Pro Gly 180 185 190Phe
Lys Arg Lys 19515441DNASaccharomyces cerevisiae 15atgaagttgg
ttaacttttt aaaaaagctg cgcaatgagc aggttaccat agaactaaaa 60aacggtacca
ccgtttgggg tacactgcag tcggtatcac cacaaatgaa tgctatctta
120actgacgtga agttgaccct accacaaccc cgactaaata aattgaacag
taatggtatt 180gcgatggcta gtctgtactt gactggagga cagcaaccta
ctgcaagtga caacatagca 240agtttgcaat acataaacat tagaggcaat
accataagac agataatctt acctgattcc 300ttgaacctgg attcactttt
ggttgaccaa aagcaactta attccctaag aagatcgggt 360caaattgcaa
atgaccccag caaaaagaga aggcgcgatt ttggtgcacc agcgaataaa
420aggccaagaa gaggtctatg a 44116146PRTSaccharomyces cerevisiae
16Met Lys Leu Val Asn Phe Leu Lys Lys Leu Arg Asn Glu Gln Val Thr1
5 10 15Ile Glu Leu Lys Asn Gly Thr Thr Val Trp Gly Thr Leu Gln Ser
Val 20 25 30Ser Pro Gln Met Asn Ala Ile Leu Thr Asp Val Lys Leu Thr
Leu Pro 35 40 45Gln Pro Arg Leu Asn Lys Leu Asn Ser Asn Gly Ile Ala
Met Ala Ser 50 55 60Leu Tyr Leu Thr Gly Gly Gln Gln Pro Thr Ala Ser
Asp Asn Ile Ala65 70 75 80Ser Leu Gln Tyr Ile Asn Ile Arg Gly Asn
Thr Ile Arg Gln Ile Ile 85 90 95Leu Pro Asp Ser Leu Asn Leu Asp Ser
Leu Leu Val Asp Gln Lys Gln 100 105 110Leu Asn Ser Leu Arg Arg Ser
Gly Gln Ile Ala Asn Asp Pro Ser Lys 115 120 125Lys Arg Arg Arg Asp
Phe Gly Ala Pro Ala Asn Lys Arg Pro Arg Arg 130 135 140Gly
Leu14517333DNASaccharomyces cerevisiae 17atgtcttcac aaataattga
tcgtccaaaa catgaactct ctagagcaga attagaggaa 60ctagaagaat ttgaattcaa
acatggtcca atgtccctga taaatgatgc tatggtgaca 120agaacacctg
tgataatctc attaagaaac aatcataaaa taatagcgag agtgaaagct
180ttcgacaggc attgtaatat ggttttagaa aatgtgaagg agctttggac
agagaagaag 240ggcaaaaatg taattaatcg ggaaagattc ataagtaaac
tattcttaag aggtgattca 300gttatcgttg tgttaaaaac ccctgttgag taa
33318110PRTSaccharomyces cerevisiae 18Met Ser Ser Gln Ile Ile Asp
Arg Pro Lys His Glu Leu Ser Arg Ala1 5 10 15Glu Leu Glu Glu Leu Glu
Glu Phe Glu Phe Lys His Gly Pro Met Ser 20 25 30Leu Ile Asn Asp Ala
Met Val Thr Arg Thr Pro Val Ile Ile Ser Leu 35 40 45Arg Asn Asn His
Lys Ile Ile Ala Arg Val Lys Ala Phe Asp Arg His 50 55 60Cys Asn Met
Val Leu Glu Asn Val Lys Glu Leu Trp Thr Glu Lys Lys65 70 75 80Gly
Lys Asn Val Ile Asn Arg Glu Arg Phe Ile Ser Lys Leu Phe Leu 85 90
95Arg Gly Asp Ser Val Ile Val Val Leu Lys Thr Pro Val Glu 100 105
11019306DNASaccharomyces cerevisiae 19atgactatga atggaatacc
agtgaaatta ttaaatgagg cacagggaca tatcgtttct 60ctggagctaa caacgggagc
gacttatcgt ggtaaacttg ttgaaagcga agatagcatg 120aacgtacagc
taagagatgt aatagctaca gagccccagg gggctgtaac acacatggat
180caaatattcg tacgtgggtc acagatcaaa tttatcgttg ttccagatct
cttaaagaat 240gcaccattat tcaaaaaaaa ctcatcaaga cctatgccac
caataagagg acctaagaga 300aggtga 30620101PRTSaccharomyces cerevisiae
20Met Thr Met Asn Gly Ile Pro Val Lys Leu Leu Asn Glu Ala Gln Gly1
5 10 15His Ile Val Ser Leu Glu Leu Thr Thr Gly Ala Thr Tyr Arg Gly
Lys 20 25 30Leu Val Glu Ser Glu Asp Ser Met Asn Val Gln Leu Arg Asp
Val Ile 35 40 45Ala Thr Glu Pro Gln Gly Ala Val Thr His Met Asp Gln
Ile Phe Val 50 55 60Arg Gly Ser Gln Ile Lys Phe Ile Val Val Pro Asp
Leu Leu Lys Asn65 70 75 80Ala Pro Leu Phe Lys Lys Asn Ser Ser Arg
Pro Met Pro Pro Ile Arg 85 90 95Gly Pro Lys Arg Arg
10021285DNASaccharomyces cerevisiae 21atgtcgaaca aagttaaaac
caaggccatg gtgccaccaa taaattgcat atttaacttc 60ttacaacagc aaacaccagt
aacgatatgg ttattcgagc aaatcggcat aagaatcaag 120ggtaaaatag
ttggatttga tgagttcatg aatgttgtca tcgatgaagc cgtggaaatt
180cctgtgaata gtgccgatgg taaagaagat gtggagaagg gcacgccctt
ggggaagatc 240ctgttgaaag gcgataatat cacattgata acatcagcgg actga
2852294PRTSaccharomyces cerevisiae 22Met Ser Asn Lys Val Lys Thr
Lys Ala Met Val Pro Pro Ile Asn Cys1 5 10 15Ile Phe Asn Phe Leu Gln
Gln Gln Thr Pro Val Thr Ile Trp Leu Phe 20 25 30Glu Gln Ile Gly Ile
Arg Ile Lys Gly Lys Ile Val Gly Phe Asp Glu 35 40 45Phe Met Asn Val
Val Ile Asp Glu Ala Val Glu Ile Pro Val Asn Ser 50 55 60Ala Asp Gly
Lys Glu Asp Val Glu Lys Gly Thr Pro Leu Gly Lys Ile65 70 75 80Leu
Leu Lys Gly Asp Asn Ile Thr Leu Ile Thr Ser Ala Asp 85
9023261DNASaccharomyces cerevisiae 23atgagcgaga gcagtgatat
cagcgcgatg cagccggtga acccgaagcc gttcctcaaa 60ggcctggtca accatcgtgt
aggcgtcaag cttaagttca acagcaccga atatagaggt 120acgctcgtgt
ccacggacaa ctactttaac ctgcagctga acgaagcaga agagtttgtt
180gcgggtgtct cgcacggcac cctgggcgag atattcatcc gctgcaataa
cgtgctgtac 240atcagggagc tgccgaacta a 2612486PRTSaccharomyces
cerevisiae 24Met Ser Glu Ser Ser Asp Ile Ser Ala Met Gln Pro Val
Asn Pro Lys1 5 10 15Pro Phe Leu Lys Gly Leu Val Asn His Arg Val Gly
Val Lys Leu Lys 20 25 30Phe Asn Ser Thr Glu Tyr Arg Gly Thr Leu Val
Ser Thr Asp Asn Tyr 35 40 45Phe Asn Leu Gln Leu Asn Glu Ala Glu Glu
Phe Val Ala Gly Val Ser 50 55 60His Gly Thr Leu Gly Glu Ile Phe Ile
Arg Cys Asn Asn Val Leu Tyr65 70 75 80Ile Arg Glu Leu Pro Asn
8525234DNASaccharomyces cerevisiae 25atggtttcta cccctgaact
gaagaaatat atggacaaga agatattgct gaatataaat 60ggatctagga aagtggcagg
aattttgcga ggctacgata ttttcttaaa cgtcgttctt 120gatgatgcaa
tggagataaa tggtgaagac cctgccaata accaccagct aggcttgcag
180accgtcatta ggggcaactc cataatatcc ctagaggctc tagatgccat ataa
2342677PRTSaccharomyces cerevisiae 26Met Val Ser Thr Pro Glu Leu
Lys Lys Tyr Met Asp Lys Lys Ile Leu1 5 10 15Leu Asn Ile Asn Gly Ser
Arg Lys Val Ala Gly Ile Leu Arg Gly Tyr 20 25 30Asp Ile Phe Leu Asn
Val Val Leu Asp Asp Ala Met Glu Ile Asn Gly 35 40 45Glu Asp Pro Ala
Asn Asn His Gln Leu Gly Leu Gln Thr Val Ile Arg 50 55 60Gly Asn Ser
Ile Ile Ser Leu Glu Ala Leu Asp Ala Ile65 70
7527519DNASaccharomyces cerevisiae 27atgtctgcaa atagcaagga
cagaaatcag tccaatcagg atgcgaagcg acaacagcag 60aatttcccaa agaagatttc
agaaggtgag gccgatttat atctcgacca gtataacttc 120actaccaccg
ctgctattgt aagctcagta gaccgtaaaa tcttcgttct tttgcgtgat
180ggaagaatgc tattcggtgt actaagaacc tttgaccaat atgcaaattt
gatacttcaa 240gattgcgtgg agagaatata ttttagcgaa gaaaacaaat
acgctgaaga agaccgcggc 300atattcatga ttcgtggtga aaatgttgtc
atgttaggcg aagtagacat cgataaagaa 360gatcaacccc ttgaggccat
ggaacgcata ccatttaagg aggcttggct gaccaagcaa 420aaaaatgatg
agaaaaggtt taaagaggaa acccacaaag gtaaaaaaat ggcccgccat
480ggtatcgttt acgatttcca taaatctgac atgtactaa
51928172PRTSaccharomyces cerevisiae 28Met Ser Ala Asn Ser Lys Asp
Arg Asn Gln Ser Asn Gln Asp Ala Lys1 5 10 15Arg Gln Gln Gln Asn Phe
Pro Lys Lys Ile Ser Glu Gly Glu Ala Asp 20 25 30Leu Tyr Leu Asp Gln
Tyr Asn Phe Thr Thr Thr Ala Ala Ile Val Ser 35
40 45Ser Val Asp Arg Lys Ile Phe Val Leu Leu Arg Asp Gly Arg Met
Leu 50 55 60Phe Gly Val Leu Arg Thr Phe Asp Gln Tyr Ala Asn Leu Ile
Leu Gln65 70 75 80Asp Cys Val Glu Arg Ile Tyr Phe Ser Glu Glu Asn
Lys Tyr Ala Glu 85 90 95Glu Asp Arg Gly Ile Phe Met Ile Arg Gly Glu
Asn Val Val Met Leu 100 105 110Gly Glu Val Asp Ile Asp Lys Glu Asp
Gln Pro Leu Glu Ala Met Glu 115 120 125Arg Ile Pro Phe Lys Glu Ala
Trp Leu Thr Lys Gln Lys Asn Asp Glu 130 135 140Lys Arg Phe Lys Glu
Glu Thr His Lys Gly Lys Lys Met Ala Arg His145 150 155 160Gly Ile
Val Tyr Asp Phe His Lys Ser Asp Met Tyr 165
17029288DNASaccharomyces cerevisiae 29atgcttttct tctccttttt
caagacttta gttgaccaag aagtggtcgt agagttaaaa 60aacgacattg aaataaaagg
tacactacaa tcagttgacc aatttttgaa tctgaaacta 120gacaacatat
catgcacaga tgaaaaaaaa tatccacact tgggttccgt aaggaatatt
180tttataagag gttcaacagt caggtacgtt tacttgaata agaacatggt
agatacgaat 240ttgctacaag acgctaccag aagggaggta atgactgaaa gaaaataa
2883095PRTSaccharomyces cerevisiae 30Met Leu Phe Phe Ser Phe Phe
Lys Thr Leu Val Asp Gln Glu Val Val1 5 10 15Val Glu Leu Lys Asn Asp
Ile Glu Ile Lys Gly Thr Leu Gln Ser Val 20 25 30Asp Gln Phe Leu Asn
Leu Lys Leu Asp Asn Ile Ser Cys Thr Asp Glu 35 40 45Lys Lys Tyr Pro
His Leu Gly Ser Val Arg Asn Ile Phe Ile Arg Gly 50 55 60Ser Thr Val
Arg Tyr Val Tyr Leu Asn Lys Asn Met Val Asp Thr Asn65 70 75 80Leu
Leu Gln Asp Ala Thr Arg Arg Glu Val Met Thr Glu Arg Lys 85 90
9531270DNASaccharomyces cerevisiae 31atggagacac ctttggattt
attgaaactc aatctcgatg agagggtgta catcaagctg 60cgcggggcca ggacgctggt
gggcacactg caagcgttcg actcacactg caacatcgtg 120ctgagtgatg
cagtagagac catataccaa ttaaacaacg aggagttgag tgagtccgaa
180agacgatgtg aaatggtgtt catcagagga gacacagtga ctctaatcag
cacgccctct 240gaagatgacg atggcgcagt ggagatataa
2703289PRTSaccharomyces cerevisiae 32Met Glu Thr Pro Leu Asp Leu
Leu Lys Leu Asn Leu Asp Glu Arg Val1 5 10 15Tyr Ile Lys Leu Arg Gly
Ala Arg Thr Leu Val Gly Thr Leu Gln Ala 20 25 30Phe Asp Ser His Cys
Asn Ile Val Leu Ser Asp Ala Val Glu Thr Ile 35 40 45Tyr Gln Leu Asn
Asn Glu Glu Leu Ser Glu Ser Glu Arg Arg Cys Glu 50 55 60Met Val Phe
Ile Arg Gly Asp Thr Val Thr Leu Ile Ser Thr Pro Ser65 70 75 80Glu
Asp Asp Asp Gly Ala Val Glu Ile 8533564DNASaccharomyces cerevisiae
33atgctacctt tatatctttt aacaaatgcg aagggacaac aaatgcaaat agaattgaaa
60aacggtgaaa ttatacaagg gatattgacc aacgtagata actggatgaa ccttacttta
120tctaatgtaa ccgaatatag tgaagaaagc gcaattaatt cagaagacaa
tgctgagagc 180agtaaagccg taaaattgaa cgaaatttat attagaggga
cttttatcaa gtttatcaaa 240ttgcaagata atataattga caaggtcaag
cagcaaatta actccaacaa taactctaat 300agtaacggcc ctgggcataa
aagatactac aacaataggg attcaaacaa caatagaggt 360aactacaaca
gaagaaataa taataacggc aacagcaacc gccgtccata ctctcaaaac
420cgtcaataca acaacagcaa cagcagtaac attaacaaca gtatcaacag
tatcaatagc 480aacaaccaaa atatgaacaa tggtttaggt gggtccgtcc
aacatcattt taacagctct 540tctccacaaa aggtcgaatt ttaa
56434187PRTSaccharomyces cerevisiae 34Met Leu Pro Leu Tyr Leu Leu
Thr Asn Ala Lys Gly Gln Gln Met Gln1 5 10 15Ile Glu Leu Lys Asn Gly
Glu Ile Ile Gln Gly Ile Leu Thr Asn Val 20 25 30Asp Asn Trp Met Asn
Leu Thr Leu Ser Asn Val Thr Glu Tyr Ser Glu 35 40 45Glu Ser Ala Ile
Asn Ser Glu Asp Asn Ala Glu Ser Ser Lys Ala Val 50 55 60Lys Leu Asn
Glu Ile Tyr Ile Arg Gly Thr Phe Ile Lys Phe Ile Lys65 70 75 80Leu
Gln Asp Asn Ile Ile Asp Lys Val Lys Gln Gln Ile Asn Ser Asn 85 90
95Asn Asn Ser Asn Ser Asn Gly Pro Gly His Lys Arg Tyr Tyr Asn Asn
100 105 110Arg Asp Ser Asn Asn Asn Arg Gly Asn Tyr Asn Arg Arg Asn
Asn Asn 115 120 125Asn Gly Asn Ser Asn Arg Arg Pro Tyr Ser Gln Asn
Arg Gln Tyr Asn 130 135 140Asn Ser Asn Ser Ser Asn Ile Asn Asn Ser
Ile Asn Ser Ile Asn Ser145 150 155 160Asn Asn Gln Asn Met Asn Asn
Gly Leu Gly Gly Ser Val Gln His His 165 170 175Phe Asn Ser Ser Ser
Pro Gln Lys Val Glu Phe 180 18535282DNASaccharomyces cerevisiae
35atgagtctac cggagatttt gcctttggaa gtcatagata aaacaattaa ccagaaagtg
60ttgattgtgc tgcagtcgaa ccgcgagttc gagggcacgt tagttggttt cgacgacttc
120gtcaacgtta tactggaaga cgctgtcgag tggcttatcg atcctgagga
cgagagcaga 180aatgagaaag ttatgcagca ccatggcaga atgcttttaa
gcggcaacaa tattgccatc 240cttgtgccag gcggcaaaaa gacccctacg
gaggcgttgt aa 2823693PRTSaccharomyces cerevisiae 36Met Ser Leu Pro
Glu Ile Leu Pro Leu Glu Val Ile Asp Lys Thr Ile1 5 10 15Asn Gln Lys
Val Leu Ile Val Leu Gln Ser Asn Arg Glu Phe Glu Gly 20 25 30Thr Leu
Val Gly Phe Asp Asp Phe Val Asn Val Ile Leu Glu Asp Ala 35 40 45Val
Glu Trp Leu Ile Asp Pro Glu Asp Glu Ser Arg Asn Glu Lys Val 50 55
60Met Gln His His Gly Arg Met Leu Leu Ser Gly Asn Asn Ile Ala Ile65
70 75 80Leu Val Pro Gly Gly Lys Lys Thr Pro Thr Glu Ala Leu 85
9037261DNASaccharomyces cerevisiae 37atgtccggaa aagcttctac
agagggtagc gttactacgg agtttctctc tgatatcatt 60ggtaagacag tgaacgtcaa
acttgcctcg ggtttactct acagcggaag attggaatcc 120attgatggtt
ttatgaatgt tgcactatcg agtgccactg aacactacga gagtaataac
180aataagcttc taaataagtt caatagtgat gtctttttga ggggcacgca
ggtcatgtat 240atcagtgaac aaaaaatata g 2613886PRTSaccharomyces
cerevisiae 38Met Ser Gly Lys Ala Ser Thr Glu Gly Ser Val Thr Thr
Glu Phe Leu1 5 10 15Ser Asp Ile Ile Gly Lys Thr Val Asn Val Lys Leu
Ala Ser Gly Leu 20 25 30Leu Tyr Ser Gly Arg Leu Glu Ser Ile Asp Gly
Phe Met Asn Val Ala 35 40 45Leu Ser Ser Ala Thr Glu His Tyr Glu Ser
Asn Asn Asn Lys Leu Leu 50 55 60Asn Lys Phe Asn Ser Asp Val Phe Leu
Arg Gly Thr Gln Val Met Tyr65 70 75 80Ile Ser Glu Gln Lys Ile
8539348DNASaccharomyces cerevisiae 39atgcatcagc aacactccaa
atcagagaac aaaccacaac agcaaaggaa aaaattcgaa 60ggccctaaaa gagaagctat
tctggattta gcgaagtata aagattctaa aattcgcgtc 120aaattaatgg
gtggtaaatt agttataggt gtcctaaaag gctatgatca actgatgaac
180ttggtacttg atgatacagt agaatatatg tctaatcctg atgatgaaaa
caacactgaa 240ctgatttcta aaaacgcaag aaagctaggt ttgaccgtca
taagaggtac tattttggtc 300tctttaagtt ccgccgaagg ttctgatgta
ctatatatgc aaaaatag 34840115PRTSaccharomyces cerevisiae 40Met His
Gln Gln His Ser Lys Ser Glu Asn Lys Pro Gln Gln Gln Arg1 5 10 15Lys
Lys Phe Glu Gly Pro Lys Arg Glu Ala Ile Leu Asp Leu Ala Lys 20 25
30Tyr Lys Asp Ser Lys Ile Arg Val Lys Leu Met Gly Gly Lys Leu Val
35 40 45Ile Gly Val Leu Lys Gly Tyr Asp Gln Leu Met Asn Leu Val Leu
Asp 50 55 60Asp Thr Val Glu Tyr Met Ser Asn Pro Asp Asp Glu Asn Asn
Thr Glu65 70 75 80Leu Ile Ser Lys Asn Ala Arg Lys Leu Gly Leu Thr
Val Ile Arg Gly 85 90 95Thr Ile Leu Val Ser Leu Ser Ser Ala Glu Gly
Ser Asp Val Leu Tyr 100 105 110Met Gln Lys 11541330DNASaccharomyces
cerevisiae 41atgtcagcca ccttgaaaga ctacttaaat aaaagagttg ttataatcaa
agttgacggc 60gaatgcctca tagcaagcct aaacggcttc gacaaaaata ctaatctatt
cataaccaat 120gttttcaacc gcataagcaa ggaattcatc tgcaaggcac
agttacttcg aggcagcgag 180attgctcttg ttggcctcat agatgcagaa
aatgatgaca gtctagctcc tatagacgaa 240aagaaggtcc caatgctaaa
ggacaccaag aataaaatcg aaaatgagca tgtaatatgg 300gaaaaagtgt
acgaatcaaa gacaaaataa 33042109PRTSaccharomyces cerevisiae 42Met Ser
Ala Thr Leu Lys Asp Tyr Leu Asn Lys Arg Val Val Ile Ile1 5 10 15Lys
Val Asp Gly Glu Cys Leu Ile Ala Ser Leu Asn Gly Phe Asp Lys 20 25
30Asn Thr Asn Leu Phe Ile Thr Asn Val Phe Asn Arg Ile Ser Lys Glu
35 40 45Phe Ile Cys Lys Ala Gln Leu Leu Arg Gly Ser Glu Ile Ala Leu
Val 50 55 60Gly Leu Ile Asp Ala Glu Asn Asp Asp Ser Leu Ala Pro Ile
Asp Glu65 70 75 80Lys Lys Val Pro Met Leu Lys Asp Thr Lys Asn Lys
Ile Glu Asn Glu 85 90 95His Val Ile Trp Glu Lys Val Tyr Glu Ser Lys
Thr Lys 100 10543267DNASaccharomyces cerevisiae 43atggacatct
tgaaactgtc agattttatt ggaaatactt taatagtttc ccttacagaa 60gatcgtattt
tagttggaag cttggttgct gtagatgccc aaatgaattt gctattagat
120catgttgagg aacgtatggg ctccagtagt agaatgatgg gcctagtcag
cgtccctagg 180cgttccgtta agaccataat gattgataag cctgttctgc
aggagcttac tgcgaataaa 240gttgaattga tggctaatat tgtttag
2674488PRTSaccharomyces cerevisiae 44Met Asp Ile Leu Lys Leu Ser
Asp Phe Ile Gly Asn Thr Leu Ile Val1 5 10 15Ser Leu Thr Glu Asp Arg
Ile Leu Val Gly Ser Leu Val Ala Val Asp 20 25 30Ala Gln Met Asn Leu
Leu Leu Asp His Val Glu Glu Arg Met Gly Ser 35 40 45Ser Ser Arg Met
Met Gly Leu Val Ser Val Pro Arg Arg Ser Val Lys 50 55 60Thr Ile Met
Ile Asp Lys Pro Val Leu Gln Glu Leu Thr Ala Asn Lys65 70 75 80Val
Glu Leu Met Ala Asn Ile Val 8545564DNASaccharomyces cerevisiae
45atgagtgtca gccttgagca aacgctcgga ttcagaataa aagttacgaa cgtgttggat
60gtagttactg aaggaagatt gtattcgttc aattcatcca acaacactct tactatccaa
120acaacaaaga agaatcaatc tccacaaaac ttcaaggtga taaaatgtac
attcatcaag 180catttggaag tcattggtga taagccctcg tttaactcat
tcaaaaagca acaaatcaaa 240ccctcatatg tcaacgtgga aagagttgag
aagcttttga aagaaagtgt aatagcatct 300aaaaagaaag aactcttaag
gggcaagggt gtgagtgcag agggtcagtt cattttcgat 360caaatcttca
agaccatagg agatactaag tgggtggcta aagacatcat tattcttgat
420gacgttaagg tgcaacctcc atacaaggtc gaagatatca aagtgctaca
tgagggaagt 480aaccaatcca ttacattaat tcaaagaata gtggaaagaa
gctgggagca gctagaacaa 540gacgatggta ggaaaggtgg atag
56446187PRTSaccharomyces cerevisiae 46Met Ser Val Ser Leu Glu Gln
Thr Leu Gly Phe Arg Ile Lys Val Thr1 5 10 15Asn Val Leu Asp Val Val
Thr Glu Gly Arg Leu Tyr Ser Phe Asn Ser 20 25 30Ser Asn Asn Thr Leu
Thr Ile Gln Thr Thr Lys Lys Asn Gln Ser Pro 35 40 45Gln Asn Phe Lys
Val Ile Lys Cys Thr Phe Ile Lys His Leu Glu Val 50 55 60Ile Gly Asp
Lys Pro Ser Phe Asn Ser Phe Lys Lys Gln Gln Ile Lys65 70 75 80Pro
Ser Tyr Val Asn Val Glu Arg Val Glu Lys Leu Leu Lys Glu Ser 85 90
95Val Ile Ala Ser Lys Lys Lys Glu Leu Leu Arg Gly Lys Gly Val Ser
100 105 110Ala Glu Gly Gln Phe Ile Phe Asp Gln Ile Phe Lys Thr Ile
Gly Asp 115 120 125Thr Lys Trp Val Ala Lys Asp Ile Ile Ile Leu Asp
Asp Val Lys Val 130 135 140Gln Pro Pro Tyr Lys Val Glu Asp Ile Lys
Val Leu His Glu Gly Ser145 150 155 160Asn Gln Ser Ile Thr Leu Ile
Gln Arg Ile Val Glu Arg Ser Trp Glu 165 170 175Gln Leu Glu Gln Asp
Asp Gly Arg Lys Gly Gly 180 185471050DNASaccharomyces cerevisiae
47atgtcgcagt acatcggtaa aactatttct ttaatctctg tgactgacaa cagatatgtg
60gggctgttag aagatattga ctctgaaaag ggtaccgtga ctttgaaaga agttcgctgt
120tttggtacag aaggtcgcaa gaactggggt cctgaagaaa tttatccgaa
tcctacggta 180tacaattctg taaagttcaa cggcagtgaa gtcaaggatt
taagcatttt agatgctaac 240atcaatgaca tacagccggt tgttcctcaa
atgatgccac ccgcttcaca attccctcct 300caacaagctc aatctccacc
ccaggctcaa gctcaagcac acgtgcaaac aaacccccaa 360gttccaaagc
ccgaatccaa tgtgccagca gctgtcgctg gatatggtgt ttacacccca
420acttcgacag aaaccgctac tgctagtatg aatgataaga gcactcctca
agacaccaat 480gtaaactcgc aaagtaggga aagaggtaaa aatggtgaaa
atgagccaaa atatcaaaga 540aacaagaata gatcaagtaa tcgccctcct
caatccaacc gcaatttcaa agtcgatatt 600ccgaatgaag attttgactt
tcaatcaaat aatgcaaaat tcacgaaagg tgattccact 660gatgtggaaa
aagaaaaaga attagaatca gctgttcaca agcaggatga atctgatgag
720cagttttata ataaaaaatc gtcttttttc gacaccatct ccacttctac
tgaaactaat 780accaatatga gatggcaaga agaaaaaatg ttgaacgttg
acacctttgg acaagcttct 840gccagaccaa gatttcactc tagaggcctc
ggtcgtgggc gtggaaatta taggggaaac 900agaggaaaca gaggaagagg
cggccaacgt ggaaactacc aaaacagaaa taactaccaa 960aatgatagtg
gcgcctatca gaaccaaaac gactcgtaca gcagaccagc caaccagttt
1020tcgcaacctc cttccaacgt tgaattttaa 105048349PRTSaccharomyces
cerevisiae 48Met Ser Gln Tyr Ile Gly Lys Thr Ile Ser Leu Ile Ser
Val Thr Asp1 5 10 15Asn Arg Tyr Val Gly Leu Leu Glu Asp Ile Asp Ser
Glu Lys Gly Thr 20 25 30Val Thr Leu Lys Glu Val Arg Cys Phe Gly Thr
Glu Gly Arg Lys Asn 35 40 45Trp Gly Pro Glu Glu Ile Tyr Pro Asn Pro
Thr Val Tyr Asn Ser Val 50 55 60Lys Phe Asn Gly Ser Glu Val Lys Asp
Leu Ser Ile Leu Asp Ala Asn65 70 75 80Ile Asn Asp Ile Gln Pro Val
Val Pro Gln Met Met Pro Pro Ala Ser 85 90 95Gln Phe Pro Pro Gln Gln
Ala Gln Ser Pro Pro Gln Ala Gln Ala Gln 100 105 110Ala His Val Gln
Thr Asn Pro Gln Val Pro Lys Pro Glu Ser Asn Val 115 120 125Pro Ala
Ala Val Ala Gly Tyr Gly Val Tyr Thr Pro Thr Ser Thr Glu 130 135
140Thr Ala Thr Ala Ser Met Asn Asp Lys Ser Thr Pro Gln Asp Thr
Asn145 150 155 160Val Asn Ser Gln Ser Arg Glu Arg Gly Lys Asn Gly
Glu Asn Glu Pro 165 170 175Lys Tyr Gln Arg Asn Lys Asn Arg Ser Ser
Asn Arg Pro Pro Gln Ser 180 185 190Asn Arg Asn Phe Lys Val Asp Ile
Pro Asn Glu Asp Phe Asp Phe Gln 195 200 205Ser Asn Asn Ala Lys Phe
Thr Lys Gly Asp Ser Thr Asp Val Glu Lys 210 215 220Glu Lys Glu Leu
Glu Ser Ala Val His Lys Gln Asp Glu Ser Asp Glu225 230 235 240Gln
Phe Tyr Asn Lys Lys Ser Ser Phe Phe Asp Thr Ile Ser Thr Ser 245 250
255Thr Glu Thr Asn Thr Asn Met Arg Trp Gln Glu Glu Lys Met Leu Asn
260 265 270Val Asp Thr Phe Gly Gln Ala Ser Ala Arg Pro Arg Phe His
Ser Arg 275 280 285Gly Leu Gly Arg Gly Arg Gly Asn Tyr Arg Gly Asn
Arg Gly Asn Arg 290 295 300Gly Arg Gly Gly Gln Arg Gly Asn Tyr Gln
Asn Arg Asn Asn Tyr Gln305 310 315 320Asn Asp Ser Gly Ala Tyr Gln
Asn Gln Asn Asp Ser Tyr Ser Arg Pro 325 330 335Ala Asn Gln Phe Ser
Gln Pro Pro Ser Asn Val Glu Phe 340 345491656DNASaccharomyces
cerevisiae 49atgtcacaat ttgttggttt cggagtacaa gtggagctaa aagatgggaa
gctcattcag 60gggaaaattg ccaaagcaac ctcaaaagga ttgactttaa atgacgttca
attcggcgat 120ggtggtaaat ctcaagcttt caaagtgagg gcgtcaaggc
taaaggactt aaaggttcta 180actgttgcct ctcaatccgg gaaaaggaag
cagcaaagac aacagcagca acaaaacgat 240tataatcaaa atcgcggtga
acatattgat tggcaagatg atgatgttag taagataaaa 300caacaggaag
atttcgattt ccaaagaaat ttgggcatgt ttaacaaaaa agacgtcttc
360gcacaattaa agcaaaatga cgatatatta ccggagaata gattacaggg
acataacaga 420aagcaaaccc aattgcagca aaataattat caaaatgatg
aattggttat tccagatgca 480aagaaagatt catggaacaa gatttcttca
agaaatgagc aaagcacaca ccaatctcag 540ccgcaacaag atgctcaaga
tgatctggtt ttggaagatg atgaacatga atacgatgtc 600gatgatatcg
atgatcccaa atacctacca ataactcagt ctttgaatat tacacattta
660attcactctg caactaactc tccatccata aatgataaaa cgaaaggtac
agttataaat 720gataaggatc aggtactagc taaattaggc cagatgatca
tcagccagtc aagatccaac 780tcaacatcct tgccagctgc aaataaacaa
acaaccatca gatcaaagaa cactaagcag 840aacattccta tggctacacc
agtacaacta ctagaaatgg agagcatcac gtccgaattt 900ttcagtatta
actcggcagg gctactagaa aattttgctg taaacgcatc gttcttctta
960aagcagaaac taggtggccg tgcacgttta cgtttacaaa attctaatcc
ggaaccttta 1020gtagtaatac tagcctcaga ttccaacaga tctggtgcga
aagctctggc gttgggtaga 1080catctttgcc aaacggggca tatccgtgtc
ataacattat ttacatgttc tcaaaatgaa 1140ctacaggatt ccatggtcaa
aaagcaaaca gatatttaca agaagtgtgg cggaaaaatt 1200gttaatagtg
tatcgtcgct ggaatctgct atggaaacat taaatagccc tgtagaaata
1260gtcatcgatg ccatgcaggg atatgactgt acattgagcg atctggcggg
gacgtcggaa 1320gttattgaaa gcagaattaa aagcatgata tcatggtgta
acaaacagcg aggatctact 1380aaagtgtggt ctttggatat tccaaatggg
tttgatgcgg gatccggcat gccagatatt 1440ttcttttcag acaggattga
agcaacagga attatttgtt ctggctggcc tttgattgcc 1500atcaacaact
taattgcaaa tttgccaagt ctagaagatg ctgttttgat tgatataggt
1560ataccacagg gcgcctattc acagagaact tctttgcgta agttccaaaa
ctgtgatctt 1620ttcgtcactg acgggtccct gctattagat ttgtaa
165650551PRTSaccharomyces cerevisiae 50Met Ser Gln Phe Val Gly Phe
Gly Val Gln Val Glu Leu Lys Asp Gly1 5 10 15Lys Leu Ile Gln Gly Lys
Ile Ala Lys Ala Thr Ser Lys Gly Leu Thr 20 25 30Leu Asn Asp Val Gln
Phe Gly Asp Gly Gly Lys Ser Gln Ala Phe Lys 35 40 45Val Arg Ala Ser
Arg Leu Lys Asp Leu Lys Val Leu Thr Val Ala Ser 50 55 60Gln Ser Gly
Lys Arg Lys Gln Gln Arg Gln Gln Gln Gln Gln Asn Asp65 70 75 80Tyr
Asn Gln Asn Arg Gly Glu His Ile Asp Trp Gln Asp Asp Asp Val 85 90
95Ser Lys Ile Lys Gln Gln Glu Asp Phe Asp Phe Gln Arg Asn Leu Gly
100 105 110Met Phe Asn Lys Lys Asp Val Phe Ala Gln Leu Lys Gln Asn
Asp Asp 115 120 125Ile Leu Pro Glu Asn Arg Leu Gln Gly His Asn Arg
Lys Gln Thr Gln 130 135 140Leu Gln Gln Asn Asn Tyr Gln Asn Asp Glu
Leu Val Ile Pro Asp Ala145 150 155 160Lys Lys Asp Ser Trp Asn Lys
Ile Ser Ser Arg Asn Glu Gln Ser Thr 165 170 175His Gln Ser Gln Pro
Gln Gln Asp Ala Gln Asp Asp Leu Val Leu Glu 180 185 190Asp Asp Glu
His Glu Tyr Asp Val Asp Asp Ile Asp Asp Pro Lys Tyr 195 200 205Leu
Pro Ile Thr Gln Ser Leu Asn Ile Thr His Leu Ile His Ser Ala 210 215
220Thr Asn Ser Pro Ser Ile Asn Asp Lys Thr Lys Gly Thr Val Ile
Asn225 230 235 240Asp Lys Asp Gln Val Leu Ala Lys Leu Gly Gln Met
Ile Ile Ser Gln 245 250 255Ser Arg Ser Asn Ser Thr Ser Leu Pro Ala
Ala Asn Lys Gln Thr Thr 260 265 270Ile Arg Ser Lys Asn Thr Lys Gln
Asn Ile Pro Met Ala Thr Pro Val 275 280 285Gln Leu Leu Glu Met Glu
Ser Ile Thr Ser Glu Phe Phe Ser Ile Asn 290 295 300Ser Ala Gly Leu
Leu Glu Asn Phe Ala Val Asn Ala Ser Phe Phe Leu305 310 315 320Lys
Gln Lys Leu Gly Gly Arg Ala Arg Leu Arg Leu Gln Asn Ser Asn 325 330
335Pro Glu Pro Leu Val Val Ile Leu Ala Ser Asp Ser Asn Arg Ser Gly
340 345 350Ala Lys Ala Leu Ala Leu Gly Arg His Leu Cys Gln Thr Gly
His Ile 355 360 365Arg Val Ile Thr Leu Phe Thr Cys Ser Gln Asn Glu
Leu Gln Asp Ser 370 375 380Met Val Lys Lys Gln Thr Asp Ile Tyr Lys
Lys Cys Gly Gly Lys Ile385 390 395 400Val Asn Ser Val Ser Ser Leu
Glu Ser Ala Met Glu Thr Leu Asn Ser 405 410 415Pro Val Glu Ile Val
Ile Asp Ala Met Gln Gly Tyr Asp Cys Thr Leu 420 425 430Ser Asp Leu
Ala Gly Thr Ser Glu Val Ile Glu Ser Arg Ile Lys Ser 435 440 445Met
Ile Ser Trp Cys Asn Lys Gln Arg Gly Ser Thr Lys Val Trp Ser 450 455
460Leu Asp Ile Pro Asn Gly Phe Asp Ala Gly Ser Gly Met Pro Asp
Ile465 470 475 480Phe Phe Ser Asp Arg Ile Glu Ala Thr Gly Ile Ile
Cys Ser Gly Trp 485 490 495Pro Leu Ile Ala Ile Asn Asn Leu Ile Ala
Asn Leu Pro Ser Leu Glu 500 505 510Asp Ala Val Leu Ile Asp Ile Gly
Ile Pro Gln Gly Ala Tyr Ser Gln 515 520 525Arg Thr Ser Leu Arg Lys
Phe Gln Asn Cys Asp Leu Phe Val Thr Asp 530 535 540Gly Ser Leu Leu
Leu Asp Leu545 5505120DNAArtificial SequenceSynthetic
oligonucleotide primer 51cggagagatg gtcagtcaca 205220DNAArtificial
SequenceSynthetic oligonucleotide primer 52ttcttgctgc tgcataatcg
205320DNAArtificial SequenceSynthetic oligonucleotide primer
53atggccgaaa aggtcaacaa 205420DNAArtificial SequenceSynthetic
oligonucleotide primer 54tcaatcctcg tctcgccttt 205540DNAArtificial
SequenceSynthetic oligonucleotide primer 55caaagcttga gctcgaattc
atttttgccg tggtagttgc 405638PRTArtificial SequenceSynthetic
oligonucleotide primer 56Cys Ala Gly Gly Thr Ala Cys Cys Thr Cys
Thr Ala Gly Ala Ala Thr1 5 10 15Thr Cys Ala Cys Cys Ala Cys Thr Cys
Ala Ala Thr Cys Cys Thr Cys 20 25 30Gly Thr Cys Thr Cys Gly 35
* * * * *